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Constructing and Testing Alternative Versions of the Fama-French and 
Momentum Portfolios and Factors in the UK 
 
Abstract 
 
The aim of this paper is to construct and test alternative versions of the Fama-French 
and Carhart models for the UK market.  We conduct a comprehensive analysis of 
such models, forming risk factors using approaches advanced in the recent literature 
including value weighted factor components and various decompositions of the risk 
factors.  We also test whether such factor models can at least explain the returns of 
large firms.  Despite these various approaches, we join Michou, Mouselli and Stark 
(2007) and Fletcher (2010) in demonstrating that such factor models fail to reliably 
describe the cross-section of returns in the UK.   
 
 
The data and factors underlying this paper can be downloaded from: 
 (address in with authors versions only)  
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Constructing and Testing Alternative Versions of the Fama-French and 
Momentum Portfolios and Factors in the UK 
 
Introduction 
 
Despite its frequent use in empirical research, there is little evidence to suggest that 
the Fama-French 3-factor (FF) model adequately describes the cross-section of stock 
returns in the UK.  Michou, Mouselli and Stark (2007, hereafter MMS) show that no 
matter which “recipe” for factor construction is followed, none “emerge with a clean 
bill of health”. Fletcher and Kihanda (2005) examine whether conditional versions of 
the CAPM perform any better, whilst Fletcher (2010) extends this work further, first 
by examining a conditional version of the FF model, second by examining the 
importance of the “no arbitrage” restriction, and third by constructing “value” factors 
using the dividend yield, a method that enables the time period of study to be 
extended back to 1964.  However, Fletcher concludes that, “These results suggest we 
still have not found a good model that can capture the risk and return dynamics in UK 
stock returns”.   
 
This motivates us to extend the search for such a model in a number of different ways.  
First, we consider whether the addition of a “momentum” or “Carhart” factor can 
rescue the basic FF model.  We examine if any of the alternative specifications of the 
factors examined by MMS in association with a Carhart (1997) factor improves on the 
position, and investigate the alternative of extending the Gregory, Harris and Michou 
(2001, GHM) factor approach to obtain a UK equivalent of the US UMD momentum 
factor available on Ken French‟s website. This differs from the basic Carhart (1997) 
factor as it is formed by intersecting size and momentum portfolios.  Second, we note 
the Cremers, Petajisto and Zitzewitz (2010, hereafter CPZ) critique of the 
construction of the FF factors and follow their proposal on value-weighting (rather 
than equally weighting) the individual component portfolios of the FF factors.  Third, 
we examine the potential impact of decomposition approaches to the factors, along 
the lines of Zhang (2008) and CPZ.
1
  Fourth, we also examine whether the addition of 
                                                 
1
 A similar approach can be found in an earlier version of Fama and French (2011). 
2
 In particular, privatisations of utilities and the rail industry during our observation period have led to 
the emergence of significant new sectors.  These changes are essentially the result of political choices 
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the APT factors identified in Clare, Priestly and Thomas (1997) improves the FF 
model. Finally, we test the performance of these alternative models when factors and 
portfolios are constructed only from the largest 350 firms by market capitalisation, in 
an attempt to see if we can find a model that works at least for larger and more liquid 
firms. 
 
Given that we investigate both three and four factor models, we first test these models 
against portfolios formed by intersecting sorts on size and book-to-market (BTM), 
and by sequential sorts on size, BTM and momentum.  Both Lo and MacKinlay 
(1990) and Lewellen, Nagel and Shanken (2010) warn against relying on tests of a 
model on portfolios whose characteristics have been used to form the factors in the 
first place.  Lewellen et al. (2010, p.182) suggest, inter alia, tests based on portfolios 
formed on either industries or volatility.  MMS follow this advice by testing on 
industry portfolios, showing that no factors appear to be priced when tested against 
this more demanding set of portfolios.  In this paper, we follow the Lewellen et al. 
(2010) suggestion of testing on volatility.  We do this partly to extend the range of test 
portfolios used in the UK, given that MMS test against industry portfolios, and partly 
to avoid difficulties caused by certain industry changes in the UK.
2
  In addition, recent 
work by Brooks, Li and Miffre (2011) raise the intriguing possibility that 
idiosyncratic risk may be priced in the US, which makes testing against portfolios 
formed on the basis of past volatility interesting. 
 
Despite our attempts at alternative methods of factor construction, it turns out that 
once we move away from tests on the size and BTM portfolios, the performance of 
the models is anything but robust.  This is probably not surprising, given the recent 
results in MMS and Fletcher (2010).  One explanation for this poor performance is 
that there are limits to arbitrage, especially in smaller stocks.  These might come 
about because of liquidity constraints and limits to stock availability in smaller firms,  
or because short selling constraints might limit the ability of investors to short over-
priced “loser” stocks or over-priced “glamour” stocks (Ali and Trombley, 2006; Ali, 
Huang and Trombley, 2003).  Yet as Thomas (2006) points out, it is not difficult to 
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 In particular, privatisations of utilities and the rail industry during our observation period have led to 
the emergence of significant new sectors.  These changes are essentially the result of political choices 
and so differ from structural changes brought about by technological innovation. 
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short-sell most large capitalisation stocks.  Given that we would expect such limits to 
arbitrage to be considerably less in larger stocks, we repeat all of our tests on a sub-
sample of the 350 largest UK firms, forming both factors and test portfolios from this 
smaller universe of stocks.  The good news is that when we do so, we cannot reject 
the null hypothesis of the intercept being jointly zero for any of  our models tested 
against all our test portfolios in the first-stage Gibbons, Ross and Shanken (1989, 
GRS) test.  Further, depending on the model, in the second-stage Fama_MacBeth 
regressions, the intercept is not significantly different from zero, the value factor 
(hml) is positively priced in general, and the market risk premium is positively priced 
in rolling regressions for one version of the CPZ model when we test against the size 
and BTM portfolios.  When we test against the three-way sorted portfolios, HML, 
momentum and the market risk premium seem to be priced, and priced at plausible 
levels in some specifications of the model.  Unfortunately, the bad news is that these 
models fail to be consistent when confronted with the more demanding volatility-
based portfolio test. In tests on these portfolios, only momentum is positively priced, 
and then only when models are estimated on a non-rolling basis.   
 
We do not attempt to examine the information content of the factors, as in Mouselli, 
Michou and Stark (2008), although it is important to note that the latter does provide 
some evidence for an economic interpretation of the HML factor.  Neither is it our 
intention to undertake an analysis of the properties of long run abnormal returns using 
control portfolios, as in Lyon et al. (1999).
3
  This is an interesting, although 
demanding, task worthy of a detailed paper in its own right.  We leave this for future 
research, but we hope that it is one we can help facilitate through this paper.  
 
Data and method 
 
We collect our data by cross-matching from the following databases: The London 
Business School Share Price Database, from which we obtain the monthly stock 
returns, market capitalisation data. and also key dates of first listing and de-listing; 
Datastream; Thomson One Banker; tailored Hemscott data (from the Gregory, 
                                                 
3
 To encourage such work, we include in our datasets not only the monthly returns to control portfolios, 
but also the breakpoints for portfolio formation each year. All factors, portfolios and the corresponding 
cut-offs used in their formation are downloadable from our website (http://xfi.exeter.ac.uk/)  
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Tharyan and Tonks [2011] study of directors‟ trading) obtained by subscription; and 
hand collected data on bankrupt firms from Christidis and Gregory (2010), from 
which we obtain estimates of book value used in the computation of the BTM ratios 
used in portfolio formation.  Combining these data sources means that we are able to 
infill any missing data on any one firm in either of the Hemscott or Datastream 
sources.  Data covers the period from October 1980 to December 2010. 
 
Our central problem in forming the factors and portfolios is to find a UK proxy for the 
NYSE break points used to form the portfolios and factors on Ken French‟s website.  
This is an important issue as the London Stock Exchange exhibits a large “tail” of 
small and illiquid stocks, which are almost certainly not part of the tradable universe 
of the major institutional investors that make up a large part of the UK market.  Both 
GHM and Dimson, Nagel and Quigley (2003, hereafter DNQ) recognise the 
importance of this by using the median of the largest (by market capitalisation) 350 
firms and the 70
th
 percentile of firms respectively in forming the size breakpoints for 
market value, in both cases excluding financial stocks.  Gregory et al. (2001) base 
their BTM breakpoints on the 30
th
 and 70
th
 percentiles of the largest 350 firms, 
whereas DNQ use the 40
th
 and 60 percentiles.  More typically, other UK studies (Al-
Horani et al., 2003; Fletcher, 2001; Fletcher and Forbes, 2002; Hussain et al., 2002; 
Liu et al., 1999 and Miles and Timmerman, 1996) use the median of all firms.  For the 
reasons outlined in the introduction, we believe it is important to consider the likely 
investable universe for large investors, and given the weight of the evidence in MMS, 
we follow the largest 350 firms method found in Gregory et al. (2001, 2003) and 
Gregory and Michou (2009, hereafter GM).  However, we also construct and test our 
models using the alternative Dimson et al. (2003) 70
th
 percentile breakpoints, the Al-
Horani et al. 50
th
 percentile breakpoints together with the Fletcher (2001) and Fletcher 
and Kihanda (2005) factor construction methods.  An excellent and detailed review of 
the methods used in UK portfolio construction can be found in MMS.  Given that our 
evidence on these alternative factor specifications is similar to that in MMS, we do 
not report these tests in the paper, although full test results are available from the 
authors on request. 
 
In detail, for the FF factors, we form the following six intersecting portfolios, where 
“S” denotes small, “B” denotes big, and “H”, “M” and “L” denotes high, medium and 
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low BTM respectively: S/H; S/M; S/L B/H; B/M; B/L.  For the size cut-off we use the 
median market capitalisation of the largest 350 companies (our proxy for the Fama-
French NYSE cut-off) and we use this 350 group of stocks to set the cut-offs for the 
BTM portfolios.  
 
The smb and hml factor portfolios (see below) are then formed using the universe of 
UK main-market stocks for which market capitalisation, returns, and book values (to 
compute the BTM ratios) can be collected from any of Datastream, Hemscott, the 
LSPD or the hand-collected data from Christidis and Gregory (2010). Following 
Agarwal and Taffler (2008), who note that 22% of UK firms have March year ends, 
with only 37% of firms having December year ends, we match March year t 
accounting data with end of September year t market capitalisation data. The 
portfolios are formed at the beginning of October in year t and financial firms are 
excluded from portfolios, as are negative BTM stocks and AIM stocks. Exactly as 
described on Ken French‟s website, the factors are constructed using the 6 value-
weighted portfolios so that smb is the average return on the three small portfolios 
minus the average return on the three big portfolios, whilst hml is the average return 
on the two value portfolios minus the average return on the two growth portfolios.  
For the market return, Rm, we use the total return on the FT All Share Index, and for 
Rf, the risk free rate, we use the one month return on Treasury Bills. The market risk 
premium, rmrf is then Rm-Rf. 
 
We form the umd momentum factor based on the methodology described on the Ken 
French‟s website as follows. We use six portfolios formed on size and prior (2-12) 
returns in the construction of the factor. The portfolios, which are formed monthly, 
are the intersections of 2 portfolios formed on size and 3 portfolios formed on prior 
(2-12) return. The monthly size breakpoint is our proxy for the Fama-French NYSE 
cut-off i.e. the median firm in the largest 350 companies (excluding financials) by 
market capitalisation. The monthly prior (2-12) return breakpoints are the 30
th
 and 
70
th
 of prior (2-12) performance of the largest 350 companies each  month. Following 
the US procedure on Ken French‟s website, the momentum factor, UMD, is then 
calculated as 0.5 (S/U + B/U) - 0.5 (S/D + B/D), where U denotes the high 
momentum portfolio and D the low momentum portfolio.  However, we also form an 
alternative umd factor, umd_car, by following the approach in Carhart (1997).  By 
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construction, this factor is not inter-acted with the size factor.  Finally, noting the 
negative correlation between momentum and value factors,
4
 we investigated two 
alternative specifications of umd, one formed by inter-acting BTM (rather than size) 
with prior return, and also a decomposition of umd into a “value” and “glamour” 
component.  As neither of these specifications appeared to lead to an improved model 
we omit the tests of these factors for space reasons. 
 
Zhang (2008) and CPZ consider that a decomposition of the FF factors may be 
helpful, as does an earlier version of the Fama-French (2011) paper.  The intuition is 
that value effects may differ between large and small firms. Perhaps more 
importantly, CPZ argue that the FF practice of weighting the six constituent portfolios 
equally gives a disproportionate weight to small value stocks.  So in this paper, we 
report the result of using a Zhang (2008) type decomposition of the FF hml factor into 
small (hmls) and large (hmlb) firm components, a CPZ-style market capitalisation 
weighting of the smb, hml and umd component portfolios, which we label smb_CPZ, 
hml_CPZ, umd_CPZ respectively, and a CPZ decomposition of: the hml factor into 
big and small firms (BHML_CPZ and SHML_CPZ), together with a decomposition of 
the smb factor into a mid-cap minus large cap factor (MMB_CPZ) and a small cap 
minus mid-cap factor (SMM_CPZ). Using these factors we construct the following 
models. 
Basic models 
 Basic FF –using rmrf, smb and hml 
 Basic Carhart  – using rmrf, smb, hml and umd 
Value weighted factor components models  
 CPZ-FF – using rmrf, smb_CPZ and hml_CPZ 
 CPZ-Carhart  - using rmrf, smb_CPZ, hml_CPZ and umd_CPZ 
Decomposed factor models  
 Zhang_decomposition – using rmrf, smb, hmls, hmlb and umd  
 CPZ-decomposition- using rmrf, MMB, SMM, BHML_CPZ, SHML_CPZ 
and umd_CPZ  
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 Clifford (1997) notes a similar effect in the US. 
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We then construct the following portfolios and use the value-weighted returns on 
these portfolios in our tests:
5
  
1. 25 (5x5) intersecting size and BTM  
 5 size portfolios – 4 portfolios formed from the largest 350 firms + 
1 portfolio formed from the rest. 
 5 B/M portfolios – based on the largest 350 firms. 
 
2. 27 (3x3x3) sequentially sorting on size, BTM and momentum portfolios, 
using the size, BTM and momentum – 
 3 Size portfolios – 2 portfolios formed from the largest 250 firms + 1 
group from the rest 
 Then within each size group we create 3 BTM groups. 
 Then within each of these 9 portfolios we form 3 momentum groups. 
 
3. 25 portfolios ranked on prior 12-month standard deviation of returns. 
 
For our large firm tests, we use the basic models, the value weighted components 
models and the Zhang decomposition together with a modified the Cremers 
decomposition model as below. 
 CPZ-decomposition- using rmrf, smb_CPZ, BHML_CPZ, SHML_CPZ and 
umd_CPZ 
We then form the 25 intersecting size and BTM portfolios using  five size and five 
groups using only the largest 350 firms.,  limit the sequentially sorted size, value and 
momentum portfolios to a 2 x 2 x 3 sort and finally we limit the volatility portfolios to 
15 groups.
6
 
 
In particular, we emphasise that our choice of partitioning the size portfolios on the 
basis of the largest 350 stocks is designed to capture the investable universe for UK 
institutional investors.  Our conversations with practicing fund managers and analysts 
suggest that large international investors may view the opportunity set of UK firms as 
comprising the FTSE100 set of firms at best.  To take account of these investment 
criteria we define “large” firms as being the upper quartile of the largest 350 firms 
(excluding financials) by market capitalisation.  “Small” becomes anything not in the 
top 350 firms.
7
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 In the interests of brevity, we do not detail all of the portfolios we used here, but portfolios based on 
size, book to market, momentum and varying combinations of these are available on our website.  
6
 We also tested our results using twelve portfolios, with very similar results. 
7
 However, note that we also form an “Alternative 350 group” and “DNQ group”, together with simple 
decile and quintile portfolios for both size and book-to-market, for those who believe that alternative 
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Our decision to include only Main Market stocks follow Nagel (2001) and DNQ.  
However, we note that there has been a major change in the number of firms listed on 
the main market of the London Stock Exchange since 1997.  The number of listed 
firms in our portfolios peaks in 1997, where there are 1,393 non-financial firms with 
BTM and market capitalisations available to form the basic intersecting 5x5 size and 
BTM portfolios.  There are a further 70 firms that are included in our negative BTM 
portfolios.  This number then falls away progressively to 1,100 (plus 58 negative 
BTM) in 2000, ending up at only 563 firms by the time financials have been 
excluded, plus 21 negative B/M stocks, in 2008.  This rather alarming decline caused 
us to cross check the LSPD data with the London Stock Exchange website, and in 
December 1998 (the earliest month for which data are available on the LSE website
8
), 
there are 2,087 UK listed companies trading on the Main Market, and 307 AIM stocks 
trading.  By December 2008, this figure has fallen to 1,142 firms trading on the Main 
Market but a rise to 1,512 firms listed on AIM, of which 1,136 have market 
capitalisations of less than £25m.  Essentially, there have been a large number of 
migrations from Main Market to AIM.  Note, though, that most of these are very 
small firms.  The AIM is dominated by a large number of small, illiquid stocks.  For 
this reason, we have, for the analysis in this paper, excluded these firms from the 
factors and portfolios. 
 
Factor and portfolio summaries 
 
First, in Table 1, we report the summary statistics for our factors.  We note that none 
of the size factors, nor any of the decomposed elements of the size factors, are 
significantly different from zero.  No matter how they are defined, the hml factors are, 
at the 10% level at least, but intriguingly breaking down hml into small and large 
elements following Zhang (2008) raises the standard deviation of the elements so that 
neither element is reliably different from zero at the 10% level in two-tailed tests.  
However, using the CPZ-decomposition, SHML_CPZ is significantly different from 
zero, although BHML_CPZ fails to be.  Momentum has the highest mean of any of 
                                                                                                                                            
definitions of size and book to market are more appropriate.  Inferences on factors and test portfolios 
formed on these groupings do not change. 
8
 See http://www.londonstockexchange.com/statistics/historic/main-market/main-market.htm  
(accessed  09 Sept 2011) 
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the factors (0.77% per month), but also exhibits the greatest negative skewness and 
the largest kurtosis. Switching from Fama-French to CPZ weightings of the 
constituent portfolios increases the mean, median and the standard deviation of the 
smb and hml factors, with a marked decrease in kurtosis for the latter. For umd the 
mean and median are reduced, whilst the standard deviation is increased.  For the 
decompositions of the hml factor, conclusions on whether the effect is larger or 
smaller in big or small stocks depends upon the method of decomposition. 
 
The correlations in Table 2 reveal that despite the difference in weightings between 
FF and CPZ factors, the correlations are strongly positive: 0.92 in the case of smb, 
0.88 in the case of hml, and 0.97 in the case of umd.  Decomposing the factors reveals 
that the large and small firm components of hml are significantly positively 
correlated, but perhaps not as strongly as one might suppose.  For the Zhang (2008) 
decomposition the correlation is 0.43, whilst for the CPZ decomposition it is only 
0.33.  However, the correlation between alternative factor constructions is strong: 
0.98 for the large firm element of hml, and 0.62 for the small firm element.  The CPZ 
decomposition of the size effect reveals that MMB_CPZ and SMM_CPZ have a 
correlation of only 0.05.  One striking feature of the correlation table is the negative 
correlation between hml and momentum.  This is -0.5 in the case of the FF factors, 
and -0.4 in the case of the CPZ factors.  This led us to investigate several alternatives 
in our subsequent tests, which we do not report for space reasons.  First, we examined 
a “pure” Carhart (1997) factor, constructed without intersecting with size effects.9  
Second, we examined whether such a factor performed better in association with 
factors formed using the Al-Horani et al. (2003), Fletcher (2001), Fletcher and 
Kihanda (2005), and DNQ(2003) approaches to factor construction.  Third, we 
investigated constructing the factor by inter-acting momentum and value portfolios.  
As none of these alternatives changed our reported results in any way, we do not 
report them here, but results are available from the authors on request. 
 
We now proceed to describe the characteristics of the main portfolios described 
above.  For reasons of space we do not report these results for all the test portfolios 
we formed, but these portfolios can be downloaded from our website.  In Tables 3-5, 
                                                 
9
 The mean of this factor, at 0.287% per month, is considerably smaller than the mean of the size-
intersected UMD factor reported in Table 1.  The correlation with the UMD factor is 0.712. 
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we report the mean, standard deviation (SD), skewness, maximum, minimum, median 
and  kurtosis for each value-weighted portfolio
10
.  Table 3 reports results for 25 
intersecting size and BTM portfolios formed as described above.  The general 
tendency within size categories is for returns to increase as BTM ratio increases, 
although the effect is not completely monotonic in all of the size categories.  The 
general pattern appears to be for skewness to be more negative and kurtosis to be 
greater in the “glamour” category than the “value” category within any size group, 
with the exceptions being kurtosis in the second smallest (S2) and medium size 
groupings.   
 
Our next set of portfolios reported in Table 4 are the value-weighted 27 (3x3x3) 
portfolios sequentially sorted on size, BTM and momentum.  In the table, the first 
letter denotes size (Small, S; Medium, M; Large, L), the second the BTM category 
(Low or “Glamour”, G; Medium, M; High, or “value”, V), and the third momentum 
(Low, L; Medium, M; High, H).  Compared to (unreported) sorts based upon size and 
momentum, and to the summary factors reported in Table 1, the return patterns here 
are intriguing, as they suggest a much lower momentum effect when BTM is also 
controlled for.  Indeed, within the “small value” set of firms, momentum effects are 
actually reversed.  However, what is striking here is that sequentially sorting, as 
opposed to forming intersecting portfolios, seems to substantially dampen down any 
momentum effect.  Sequential sorting (within any size category
11
) has the effect of 
ensuring each sub-group has equal numbers of firms within it, whereas intersecting 
portfolios can have quite different numbers of firms within each portfolio.  In 
practice, it emerges that different numbers of firms within sub-categories is only an 
issue within the smallest market capitalisation quintile, where intriguingly there is a 
concentration of firms in the low momentum category.  Fully 39% of all the smallest 
quintile stocks fall into this “low momentum” group.12 
 
Finally, mindful of the arguments advanced in Lewellen et al. (2010), we report the 
characteristics of the 25 portfolios formed on the basis of prior 12-month standard 
deviations in Table 5.  These portfolios are striking in several respects.  First, past 
                                                 
10
 Note that equally weighted versions are also available for download. 
11
 Recall that by design we form the size portfolios so that the largest two size groupings by market 
capitalisation have fewer firms than the smallest size groups. 
12
 Results for size and momentum portfolios are available on our website. 
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volatility seems to predict future volatility.  As we progress from the low standard 
deviation (SD1) to high standard deviation (SD25) portfolios, standard deviations of 
the portfolio returns tend to increase.  Whilst the effect is not monotonic, the SD25 
portfolio has a standard deviation of over twice that of the SD1 portfolio.  However, 
returns do not obviously increase with standard deviation – indeed the lowest mean 
return portfolio is SD25.  Of course, this is not inconsistent with standard portfolio 
theory provided that higher risk portfolios have an offsetting effect from lower 
correlations with other assets.  There are no obvious patterns that emerge in either 
skewness or kurtosis across these portfolios. 
 
Tests of factor models 
Full sample results 
We now turn from the descriptive statistics of factors and portfolios to the central 
theme of this paper, our asset pricing tests.  Following MMS, we start with the 
standard tests of an asset pricing model described in Cochrane (2001, Ch.12) for our 
alternative Fama-French and Carhart factors on the test portfolios described above.  
The basic test requirement is that intercepts should be jointly zero. Despite the fact 
that it leads to some rather dense tables, we do not merely report the intercepts, F-
statistics and p-values from the GRS test, but instead report the individual portfolio 
coefficients.  These are revealing, particularly in the case of the standard deviation 
test portfolios.   
 
In Table 6, we report the results when models are tested using the size and BTM 
portfolios.  Each Table has three panels, where Panel A reports the results from a 
basic models, Panel B reports the results of the value-weighted factor components 
models, and Panel C reports the decomposed factor models. Turning to Table 6 Panel 
A, we see that the basic FF model passes the GRS test, and only two of the 25 
intercept terms are significant, with both of these failures are in the small firm value 
end categories.  Size exposures tend to decline as hml exposure increases in the small 
to mid size groupings.  Not surprisingly, given their construction, smb and hml 
loadings behave as one would expect as we move across size and across “value” 
categories.  The basic Carhart model does not change inferences with regard to size 
and BTM loadings.  Whilst the model passes the GRS test, there are now three 
significant intercepts, two of them in the portfolios that exhibited the same result in 
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the FF model.  The additional portfolio that fails the intercept test is another “value” 
portfolio, this time M3H.  Intriguingly, momentum only loads significantly in seven 
portfolios, with five of these being negative loadings.  There is no consistent pattern 
in these loadings.  Finally, note that the average adjusted R-squared is almost 
imperceptibly different between the two models, at 0.783 and 0.784 for the basic FF 
and Carhart models respectively.  
 
Turning to the CPZ factors in Panel B, we first observe that both models pass the 
GRS test. The mean adjusted R-squared is slightly lower than that of the basic models 
in Panel A, which is perhaps not surprising given the closer relationship between 
portfolio and factor construction in the FF definitions of factors.  For the CPZ version 
of the FF model (CPZ-FF), we detect three significant alphas, but these are only 
significant at the 10% level.  Whilst this is approximately what one would expect by 
chance, these are exactly the same portfolios that failed the intercept test in Panel A.  
Intriguingly, using the CPZ factors increases exposure to the market factor in all of 
the small to mid size portfolios, with marginal decreases in the larger portfolios.  
Introducing the momentum factor, in the last five columns of the table, leads to three 
intercepts being significant at the 5% level, with one being significant at the 10% 
level. Considering the CPZ-Carhart model, we see that there are thirteen cases of 
significant momentum exposure, and the pattern seems clearer than in the basic model 
reported in Panel A.  In the smaller portfolios, umd_CPZ exposure seems to be 
positive for “glamour” stocks.  In all but the largest size groupings it is negative in 
“value” stocks, but this effect fails to hold in the “big” portfolios, where B3 and B4 
(but not BH) have significant positive exposures.  At least as far as the four factor 
model goes, it seems that value weighting the component portfolios can have an 
important impact on inferences.   
 
Finally, in Panel C we explore the effect of disaggregating factor components.  Doing 
so seems to increase the mean R-squared compared to the aggregated models, whilst 
leaving the GRS tests unaffected.  The Zhang (2008) model, though, produces four 
significant alphas, and these are concentrated in the smallest stocks.  A particularly 
striking feature of the CPZ-decomposition is that it seems able to price the 
problematic small stock portfolios.  The only significant intercept at the 5% level is 
M3H, and at the 10% level B4H, both of which are positive.  However, both models 
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produce some odd factor loadings on the decomposed elements of the factors.  For 
example, the small stock “value” portfolios in both models show a significant positive 
exposure to the large firm hml element, whilst the largest firms have an exposure to 
the small firm element.  Whilst this may be expected if the factors were highly 
correlated, Table 2 suggests that the decomposed CPZ factors in particular are not 
highly correlated. 
 
Table 7 tests these factors on the sequentially-sorted size, BTM and momentum 
portfolios.  Surprisingly, given these portfolios bear a relationship to the way factors 
are formed, all six of our models fail the basic GRS test.  Panel A shows that the basic 
FF has six significant alphas, with four of these occurring in small size groupings.  
Adding umd improves matters marginally, with four significant alphas occurring, but 
the GRS F-test is still a highly significant 1.75.  Despite its failure to adequately 
describe the cross-section of returns in the portfolios, the momentum exposure effects 
are interesting, and confirm the effects observed in Table 4 that momentum exposure 
is not consistent across size and BTM groupings. 
 
Table 7 Panel B proves that changing the factor component weightings does not 
improve the performance of either model.  The CPZ-FF model produces seven 
significant alphas, five of them amongst smaller firms, whilst the CPZ-Carhart model 
produces a pretty much identical result.  Intriguingly, of the 20 significant umd_CPZ 
loadings, 18 of them are negative. 
 
Finally, in Panel C we report the decomposed factor model results.  These 
decompositions do nothing to rescue the models, with five significant alphas in the 
Zhang (2008) model and six in the CPZ-decomposition.  Note that the prominence of 
negative umd loadings remains in these models.   Overall, the disappointing ability of 
any of these models to price portfolios which ultimately reflect, at least to some 
degree, the characteristics used to form the factors, is not promising.  With that in 
mind, we now turn to the more demanding tests based upon our volatility-ranked 
portfolios. 
 
Overall, the results in Table 8 are perhaps better than one might expect given that Lo 
and MacKinlay (1990) and Lewellen et al. (2010) counsel against testing a model on 
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portfolios whose characteristics have been used to form the factors.  In the basic FF 
model (Panel A), we see that there are three significant alphas and that the model fails 
the GRS test, at the 10% level.  However, the four factor model produces only two 
significant alphas and passes the GRS test.  Particularly interesting are the factor 
loadings across these portfolios.  In both models, beta (market factor) exposure 
increases from 0.71 to 1.22 for both models as one moves up from the SD1 to the 
SD25 portfolio, and the exposure to the smb factor also tends to increase, although 
neither effect is monotonic.   No such clear patterns emerge in hml exposure, but it is 
noticeable that the five riskiest portfolios have a significant negative exposure to the 
factor.  Finally, there is no obvious pattern in umd exposure.  The beta effect is 
particularly important given the portfolio returns discussion above, in that it appears 
that the added riskiness of the high standard deviation portfolios is systematic, not 
idiosyncratic, and yet returns do not obviously increase in line with this exposure as 
theory suggests.  This, we suspect, may be important in explaining the failures which 
we discuss later.   
 
In Panel B, we see the effect of changing to the CPZ weightings.  For the CPZ-FF 
model, the GRS test fails at the 10% level, and the number of significant alphas is 
three.  The CPZ-Carhart model passes this test, though with four significant alphas.  
As in the basic tests of Panel A, the less risky portfolios have positive alphas.  Here, 
the most risky (SD25) has a negative alpha.  We also observe that three out of the five 
riskiest portfolios have a significant positive exposure to umd, with no significant 
exposures amongst the least risky groups, which suggests that momentum may be 
capturing some risk characteristic, although not in a totally convincing fashion.  
Finally, an interesting feature of the CPZ weightings is that they increase the range of 
observed betas, with the riskiest portfolios now having betas of 1.32 and 1.33 from 
the three and four-factor models respectively. 
 
In Table 8 Panel C, we report the results using decomposed factors.  First note that we 
cannot reject the null hypothesis for either model.  Zhang (2008) decomposition again 
shows the pattern of positive alphas amongst the less risky portfolios.  For this model, 
decomposing hml seems to dampen down the variation in betas slightly, compared 
with the basic Carhart-type model in Panel A.  It is also notable that hmlb and hmls 
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exposures tend to have opposite signs.  A similar effect is observed in the CPZ-
decomposition of hml.   
In conclusion, on the first stage tests, the various specifications of the Carhart model 
all pass the GRS test when tested, as suggested by Lewellen et al. (2010), on 
volatility-ranked portfolios.  This is perhaps surprising, given the results from testing 
on the sequentially sorted portfolios, and so we tested our factors on 5x5 portfolios 
sorted by intersecting size and momentum.  The (unreported) tests show that we can 
reject the null hypothesis of alphas not being jointly significantly different from zero 
for all our models.  It seems that the real difficulty for our models is pricing 
momentum effects, particularly in small stocks.  We return to this point later. 
 
We now turn to the second-stage regression tests, and in Table 9 we show the results 
from Fama-MacBeth (1973) estimation process using both the assumption of constant 
parameter estimates (the “Single” regression columns) and rolling 60-monthly 
estimated coefficients (the “Rolling” regression columns) when we test on the 25 size 
and BTM portfolios.  We show results for both three and four factor models, and the 
estimates are expressed in terms of percent per month. The t-statistics shown are after 
Shanken (1992) corrections for errors-in-variables problem.  The p-values 
corresponding to these corrected t-statistic are also shown.  Panel A shows the results 
from the basic FF and basic Carhart models in the top rows, whilst the bottom rows 
show the results using CPZ value weighted components Model.  Panel B shows 
results from the decomposed factor models of Zhang (2008) and CPZ.  As we 
estimate these regressions using excess returns, the intercept should be zero and the 
coefficients on the factors should represent the market price of the risk factor.   
 
Turning to Table 9, Panel A, we observe that for the basic FF model, whether 
estimated on a fixed or rolling basis, we cannot reject the null hypothesis that pricing 
errors are significantly different from zero.  However, when estimated on a rolling 
basis the intercept term (_cons) is significantly positive.  For both bases, only hml is 
priced, and at a level which is not inconsistent with the factor mean in Table 1. 
However, rmrf is nowhere near being significant.  The basic Carhart model represents 
an improvement in terms of both rolling and single regressions satisfying the chi-
squared test and the zero-intercept requirement.  Note, though, that the implied price 
of hml shows a marked increase.  The cross-sectional R-squared is also slightly 
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higher.  Using CPZ weightings does not change any of the inferences, and except 
where rolling regressions are used in the context of the CPZ-FF model, the zero 
intercept requirement is satisfied.  The implied factor price on hml_CPZ is greater 
than that on hml, and in all cases the price is higher than the mean value reported in 
Table 1. 
 
We next turn to the decomposed factor model results in Table 9 Panel B.  Looking at 
the Zhang (2008) decomposition first, we see that the chi-squared test and zero-
intercept requirements are both met.  Both hmls and hmlb elements appear to be 
significantly priced in the single regression model, although the implied price of the 
former is a good deal higher than implied by the Table 1 mean.  Using rolling 
regressions results in lower estimates and hmls being not significantly priced.  Again, 
there is no hint that either market risk or smb is a priced factor.  As regards the CPZ 
decomposition, inferences from the single regression model are similar to those from 
the Zhang (2008) model.  Both BHML_CPZ and SHML_CPZ are priced.  However, in 
the rolling regression test whilst these two remain significantly priced, the umd_CPZ 
factor is also significantly priced, and all three factors are priced at a level that is 
consistent with their sample period means.   
 
When we try and run the Fama-MacBeth tests on the sequentially sorted size, BTM 
and momentum portfolios, the results are disappointing.  First, for all our models no 
matter whether they are run on a single or rolling estimation basis, we can reject the 
null hypothesis that the pricing errors are jointly zero.  Turning to the individual 
models, in Panel A we see that for the basic FF model the intercept is significantly 
positive for both single and rolling estimates, although in the case of the former hml is 
significantly priced.  For the basic Carhart model, although the intercept is zero and 
hml appears to be priced, the chi-squared test strongly rejects the null of no significant 
pricing errors. The CPZ weighted factors fail to rescue either model, in that besides 
the chi-squared test failure, all of the intercept terms are significantly positive, at the 
10% level at least.    
 
The decomposition models in Panel B of Table 10 are a modest improvement, with 
components being priced in a fashion consistent with pricing in the Table 9 tests, but 
of course the chi-squared test is significant (at the 10% level in the case of the CPZ 
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model) and earlier we saw that the GRS test was failed for these portfolio and model 
combinations. 
 
In Table 11, we report the results of the Fama-Macbeth test on the 25 standard 
deviation portfolios.  Turning first to Panel A, we first note that the chi-squared tests 
show that we can accept the null hypothesis that pricing errors are jointly zero for all 
the models.  Unfortunately, for the basic FF model we see that whether a single 
regression or rolling regressions are employed, no factors are significantly priced, but 
that the constant is significant and positive.  For the basic Carhart model, conclusions 
vary according to whether a single regression or rolling regressions are employed.  
For the former, nothing is priced, but for the latter, the constant is significant and hml 
is significantly priced at the 10% level.  Using CPZ weightings, the constant is always 
significant and positive.  In the rolling regression version of the CPZ-FF model, the 
market factor is negatively priced.  In both the single and rolling versions of the CPZ-
Carhart model, none of the factors are priced.  Turning to the decomposed factor 
results in Table 11, Panel B, we again see that we can accept the null hypothesis of no 
significant pricing errors for all our models.  Unfortunately for the Zhang (2008) 
decomposition, nothing is priced except for the constant term in the rolling 
regressions.  With the CPZ decomposition run on a single regression basis, umd_CPZ 
is priced, although at a level that is roughly twice its sample period mean.  However, 
when we switch to rolling regressions, we observe that the sign on umd_CPZ 
switches, although the coefficient is insignificant, and that BHML_CPZ now appears 
to be priced.  However, the level of pricing implied is some five times its sample 
mean. 
 
In conclusion on these pricing tests, if we follow the Lewellen et al (2010) 
recommendations of looking at GRS and chi-squared tests, examining whether 
constant terms are significant, and checking whether the implied prices of factors 
seem plausible, we are forced to be sceptical on whether these models actually tell us 
anything about risk pricing in the UK.   
 
One interesting feature of the tests is that when the models are tested on the portfolios 
used to form the factors, the single regression tests yield slightly higher cross-
sectional R-squared than the rolling regressions.   This is consistent either with a 
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mean reversion effect in the factor loadings in these portfolios, or with the rolling 
regressions simply being noisier estimates of the true factor loadings.   However, we 
do not observe such an effect when testing models on the volatility-ranked portfolios, 
when there is little to choose between the single and rolling regressions.  Indeed, if 
anything the rolling regression approach provides weak evidence that hml (or a 
component of it in the case of the decomposed CPZ model) may be priced in the CPZ 
and decomposed models, whereas the single regression approach suggests otherwise.  
Given the weak explanatory power of these models, it is unwise to make too much of 
this, but it may be that factor loadings are more likely to be time varying when test 
portfolios are formed on characteristics that are not used in factor construction.  
Although we do not formally test this conjecture here, we note that this is entirely 
consistent with the evidence on industry factor loadings reported in Fama and French 
(1997) and Gregory and Michou (2009). 
 
Before we reject these factor models totally, we run two further groups of tests.  First, 
we undertake the robustness checks described below, in order to first test whether 
omitted variables explain our results, and second to see whether the period over which 
factor loadings are estimated has any impact.  Then, motivated by the results above 
which suggest that the models have particular difficulty in pricing smaller stocks, we 
examine whether an adequate asset pricing model can be established for larger stocks. 
 
 
Robustness checks 
Our first robustness checks extend the above models by including two variants of the 
Clare, Priestly and Thomas (1997) APT model.  We do this because, if such APT 
factors are priced, and in a manner not fully captured by size, BTM and momentum-
based factors, then the above results might be explained by an omitted variables 
problem.  First, we simply run the Clare et al. (1997) base model with all their 
variables excluding retail bank lending.
13
  Second, we include their variables as an 
extension to the FF and Carhart models.  They do not appear to add anything to the 
                                                 
13
 We exclude bank lending for several reasons.  First, the data is not currently available as a monthly 
series for our whole sample period.  Second, Clare et al (1997) use the first difference of the natural 
logarithm of bank lending and as we find the series has negative values, using their definition on our 
observed data series is not possible here.  We also note that this data series is extremely volatile on a 
monthly basis.   
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basic FF and Carhart models, and none of these variables are priced in the Fama-
MacBeth regressions, and so we do not report the results here.  
 
Kothari, Shanken and Sloan (1995) show that conclusions drawn on tests of the 
CAPM are sensitive to the period over which betas are estimated.  To test whether 
such an effect is important in the UK, we follow Fletcher (2010) and run tests using 
quarterly data.  The principal effect on our results is that the spread of observed betas 
appears to increase in tests using the 25 standard deviation portfolios.  However, our 
observations on the pricing of risk factors in the second stage regression tests do not 
change.   
 
Whilst results from the robustness checks above are not reported for space reasons, 
they are available from the authors on request. 
 
Large firm tests 
Fama and French (2011) note that smaller stocks are particularly challenging to price.  
As we observe above, whilst there may be good reasons why arbitrage activity is 
restricted in smaller stocks, those reasons do not apply to the universe of larger and 
more liquid stocks.  As a proxy for this tradable universe, we next limit our factor 
formation and test portfolios to the largest 350 firms (excluding financials) by market 
capitalisation.
1415
  Factor means are close to zero for smb, 0.32% per month for hml, 
and 0.63% per month for umd.  Our test portfolios are the 5x5 size and BTM sorts as 
before, but for the sequential portfolios we use a 2x2x3 sort, giving 12 portfolios, and 
we also form 12 prior volatility portfolios.   
 
We do not report the detailed GRS tests for each set of portfolios as we do for the full 
sample, but instead report just the GRS F-test statistic, the associated p-value, and the 
average adjusted R-squared across all the test portfolios.  These results are reported in 
Table 12, and the results are striking.  Using each of our 6 models, and each of our 
three portfolio formation methods, we only reject the null hypothesis of alphas being 
jointly zero in one case, which is for the CPZ-FF model tested on the standard 
                                                 
14
 Note that this is a proxy for the FTSE 350 index, which was unavailable at the start of our study 
period. 
15
 We are grateful to the editor, Peter Pope, for suggesting these large firm only tests. 
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deviation portfolios. The FF models do well when tested on the size and BTM 
portfolios, and the Carhart models do better when tested on the size, BTM and 
momentum portfolios, which is not surprising given that as Fama and French (2011) 
observe, these models are playing “home games”.  Note also that the decomposed 
factor models of Zhang (2008) and CPZ seem to do a little better than the aggregated 
models.  
 
Tables 13-15 then report the full Fama-MacBeth tests.  Turning to the tests based on 
size and BTM sorted portfolios first, we see that the Table 13, Panel A results suggest 
that the basic FF model has an insignificant chi-squared test for both single and 
rolling regressions, with a constant term not significantly different from zero. The hml 
factor seems to be priced at plausible levels in both specifications, and although rmrf 
has a positive coefficient, no other factors are significantly priced.  Moving to the 
basic Carhart model does not change these basic conclusions, and neither does the 
adoption of the CPZ weightings of the factor components make much difference. 
 
In Table 13, Panel B, we examine the Zhang (2008) and CPZ decomposition models, 
first noting that we cannot reject the null hypothesis of no jointly significant pricing 
errors for either model no matter how the coefficient estimates are formed.  In the 
Zhang (2008) model only hmlb is priced, suggesting that the value premium is more 
important in the largest sub-set of firms.  However, when the CPZ-decomposition 
model is estimated on a single regression basis, both BHML_CPZ and SHML_CPZ 
appear to be priced.  These conclusions change when the model is estimated on a 
rolling basis, when the market risk premium, rmrf, and BHML_CPZ are priced.  
Taken as a whole, these results suggest that hml is consistently priced, that the large 
firm element of this value premium is consistently priced, but that conclusions on the 
pricing of other factors are sensitive both to the model employed and on whether or 
not rolling estimates are made.   
 
We next examine the performance of these models when tested against size, BTM  
and momentum portfolios.  Table 14, Panel A reveals that both the basic and CPZ 
versions of the FF models fail the chi-squared test when estimated using rolling 
regressions.  Furthermore, none of the factors in either version of the model are 
priced.  When we switch to the basic Carhart model, estimated on a single regression 
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basis, both hml and umd appear to be priced, the intercept term is zero, and we cannot 
reject the null hypothesis of no significant pricing errors. However, the implied prices 
of the factors are some way in excess of the sample means.  We also note that the 
market factor is close to being significant at the 10% level, although the factor price 
implied again seems high.  When we estimate the model on a rolling basis, we can 
reject the null hypothesis and no factors are priced.  For the CPZ-Carhart model, 
whilst we are not able to reject the null hypothesis for either single or rolling 
regression estimates and the intercept is not significantly different from zero in either 
case, the conclusion on which factor is priced differ according to how the regression 
is estimated.  For the single regression basis, hml_CPZ is priced, whilst for the rolling 
regression basis it is umd_CPZ that is priced. 
 
The decomposed models in Table 14 Panel B all pass the chi-squared test for the joint 
significance of pricing errors, and in all cases the intercept term is insignificant.  
When we estimate the Zhang (2008) model on a single regression basis, it appears 
that rmrf, hmls, hmlb and umd factors are all priced.  Unfortunately, whilst the hml 
components and momentum are priced at plausible levels, the implied price of the 
market factor, at 1.6% per month, seems to be three times higher than might 
reasonably be expected.  When we switch to estimating the model on a rolling basis, 
only hmls is priced.  The alternative CPZ specification, estimated on a single 
regression basis, again shows that rmrf and momentum are priced, along with SHML.  
Once again, though, the implied price of the market risk factor is implausible.  When 
estimated on a rolling regression basis, only SHML_CPZ and umd_CPZ are priced.  
Taken as a whole, it seems the Fama and French (2011) conclusion, that portfolios 
formed using size and momentum are difficult to price, remains even when we limit 
the model to larger and more liquid firms. 
 
As before, we conclude our asset pricing tests by employing our portfolios formed on 
the basis of prior 12-month standard deviation.  From the tests in Panel A, it is clear 
that we can reject the basic FF model no matter how the factors are formed.  Despite 
the chi-squared tests being insignificant, factors are never priced at levels even close 
to being significant.  A similar conclusion is reached when estimating the basic 
Carhart model on a rolling basis.  When the models are estimated using a single 
regression, umd and umd_CPZ are both priced, but at implausibly high levels.  
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Finally, we turn to the decomposed models in Table 15, Panel B.  Briefly summarised, 
disaggregation adds little to the Carhart models described earlier.  In both cases, 
momentum is priced only when single regression estimates are made.  Whilst the 
implied prices are still high, they are somewhat dampened down compared to the 
estimates from Panel A. Unfortunately, then, it appears that even restricting the 
pricing model to large firms fails to lead to a wholly convincing model when subject 
to the more stringent  tests suggested by Lewellen et al. (2010). 
 
Conclusion 
Our first contribution in this paper has been to test multiple versions of the FF and 
Carhart models, using different approaches to factor construction, including the 
market capitalisation weightings of the constituent components of smb and hml along 
the lines suggested by Cremers et al. (2010).  We also extend these basic models by 
including the factor decompositions suggested by Zhang (2008) and Cremers et al. 
(2010).  Our second contribution is then to subject these models to various robustness 
checks, including the addition of the Clare et al. (1997) APT factors, the examination 
of quarterly estimation of factor loadings, and testing the model using factors and test 
portfolios formed from larger and more liquid firms.  Throughout, we are mindful of 
the “sceptical” approach to asset pricing advocated by Lewellen et al. (2010) and 
subject our asset pricing models to the following requirements: i) that they have to 
price portfolios formed on the basis of a variable not used to form the factors 
themselves (and here we follow their suggestion of using test portfolios formed on the 
basis of prior volatility); ii) requiring that in addition to satisfying the null hypothesis 
of no jointly significant pricing errors, intercepts should be zero, and iii) that the 
implied factor prices should be plausible.  Whilst we can find models that price BTM 
portfolios, at least when we restrict the analysis to larger firms, as Fama and French 
(2011) note, such models are playing “home games”.  Unfortunately, when confronted 
with “away games”, such models prove to be anything but robust. 
 
The results of our asset pricing tests confirm and extend the findings of MMS by 
applying tests to a wider set of portfolios over a longer time frame (up to December 
2010 as opposed to December 2003) and also by adding tests based on the 4-factor 
Carhart model.  Along with Fletcher (2010), we are able to provide no comfort for 
those seeking to employ unconditional factor models to explain or analyse the cross-
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section of UK stock returns.  What we do not attempt here is to test whether 
conditional versions of the factor models might explain the cross-section of returns.  
One attempt, in Gregory and Michou (2009), shows that conditional versions of the 
CAPM and three-factor models as employed by Ferson and Harvey (1999) and Fama 
and French (1997) are unlikely to be the solution. More recently, Fletcher (2010) 
finds that a conditional version of the FF model is the best performing model in his 
range of tests, although it performs poorly in out of sample tests. However, 
conditional versions using the frameworks of any of Jaganathan and Wang (1996), 
Lewellen and Nagel (2006)
16
 or Koch and Westheide (2009) may offer a way 
forward.   
 
A further possibility is that the estimation window for factor loadings matters.  In the 
spirit of Kothari et al. (1995), we have examined whether quarterly estimation 
windows make a difference, finding that they do not.  A longer run series of data, 
such as that used in Fletcher (2010), might allow testing using annual estimation of 
factor loadings, as in Kothari et al. (1995).  Such an approach would be interesting if 
factor loadings were time varying but mean-reverting.  Alternatively, we could 
explore the other extreme.  If factor loadings are time-varying, but with no tendency 
to mean revert, then using long run estimation windows may bias our tests against our 
factor models, even if they hold.  We note that UK regulators tend to favour the 
estimation of betas using daily or weekly betas, rather than monthly betas.  So an 
interesting question for future research is whether either very long windows using 
annual data, or alternatively much shorter windows using daily or weekly data, would 
result in more reliable models.   
 
Alternatively, it may be that there are simply better factors that might explain the 
cross-section of returns.  Chen, Novy-Marx and Zhang (2011) propose supplementing 
the market factor with factors reflecting investment and return on equity.  Other 
candidates for potential factors might include variables related to financial distress. 
 
                                                 
16
 Note that although Lewellen and Nagel (2006) reject the idea of the conditional CAPM explain 
returns, a more recent paper by O‟Doherty (2009) claims that it can explain the financial distress 
anomaly. 
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A further potential line of enquiry is to examine whether asset pricing tests are better 
tested using implied, rather than realised, cost of capital.  One argument, found in Lee 
et al. (2009), is that models of expected return fail asset pricing tests because realised 
returns are “extremely noisy” proxies for expected returns.  Using an alternative 
model of implied cost of capital, Hou et al. (2010) show that some anomalies found in 
realised returns disappear in tests using implied returns.   
 
Of course, our suggestions above assume that empirically observed effects such as the 
“value” premium and momentum are manifestations of rational risk pricing.  For 
example, Campbell and Vuolteenaho (2004) and Zhang (2005) provide plausible 
explanations as to why the “value” premium might be observed, whilst Bulkley and 
Nawosah (2009) suggest a rational-risk pricing explanation for the momentum effect.  
In contrast, Lewellen and Nagel (2006) argues that the value premium is too large to 
be explained by time-varying beta effects, whilst most recently Antoniou, Doukas and 
Subrahmanyam (2012)  show that momentum strategies only yield significant returns 
when investors are optimistic.  Whether Fama‟s (1991) hope for a “coherent story” on 
pricing such effects is realised ultimately depends on the answer to the deeply 
controversial question of whether value and momentum effects are in part attributable 
to behavioural effects. 
  
Meanwhile, until a convincing model of UK asset pricing comes along, we can only 
caution against reliance on US-derived factor models in empirical tests.  There may be 
a case for using control firms whose characteristics are matched to those known to be 
associated with asset returns.  This may be viewed as unsatisfactory and atheoretical, 
as Bulkley and Nawosah (2009) note, but it may also be the pragmatic solution to the 
dilemma of estimating long run abnormal returns in research.  That said, a counter-
argument is that there may be too many potential criteria against which to match.  
Future research could usefully examine which criteria are important to match against 
by running simulation tests along the line of those undertaken by Lyon et al. (1999) 
and Loughran and Ritter (2000). 
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Table 1: Summary statistics for the alternative Fama-French and Carhart (Momentum) factors, October 1980 to December 2010 
stats rm
rf 
sm
b
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m
l 
u
m
d
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b
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P
Z 
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m
l_C
P
Z 
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m
d
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P
Z 
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m
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h
m
lb
 
M
M
B
_C
P
Z 
SM
M
_C
P
Z 
B
H
M
L_C
P
Z 
SH
M
L_C
P
Z 
mean 0.51% 0.09% 0.31% 0.77% 0.26% 0.37% 0.68% 0.31% 0.34% 0.11% 0.15% 0.33% 0.38% 
sd 4.67% 3.23% 3.40% 4.16% 4.18% 3.72% 4.76% 4.94% 3.94% 3.15% 2.58% 4.08% 4.22% 
skewness -1.006 0.416 -0.675 -1.262 0.416 -0.539 -0.986 1.268 -0.399 0.170 0.060 -0.256 -0.597 
max 13.28% 17.73% 13.16% 14.06% 19.07% 13.09% 19.28% 34.50% 12.03% 19.05% 9.86% 14.81% 23.97% 
min -27.06% -11.83% -21.08% -27.37% -14.22% -18.32% -31.10% -22.76% -17.06% -14.62% -9.62% -16.17% -26.59% 
p50 0.98% -0.03% 0.39% 0.80% 0.07% 0.49% 0.56% 0.14% 0.34% 0.03% 0.07% 0.34% 0.25% 
kurtosis 6.509 6.363 10.04 10.873 5.271 5.903 10.337 15.72 5.119 7.877 4.71 4.794 13.618 
 
The Table reports the summary statistics for alternative definitions of the Fama-French and Carhart (momentum) factors.  Rmrf is the market risk 
premium, smb, hml and umd are as defined in the text and on Ken French‟s website, with breakpoints formed using the largest 350 UK firms.  
Smb_CPZ, hml_CPZ and umd_CPZ are formed using the market capitalisations of the intersecting size and book-to-market (BTM), and size and 
momentum portfolios as described in Cremers et al. (2010).  hmls and hmlb are decompositions of the hml factor as in Zhang (2008), whilst 
MMB_CPZ is the mid-cap minus large cap factor, SMM_CPZ is the small cap minus mid-cap factor, and BHML_CPZ and SHML_CPZ are the 
decompositions of the hml_CPZ portfolio, all as described in Cremers et al. (2010).  Statistics reported are the mean, standard deviation (SD), 
skewness, maximum (max), minimum (min), median (p50), and kurtosis.   
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Table 2: Correlations 
  rm
rf 
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Z 
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Z 
B
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M
L_C
P
Z 
SH
M
L_C
P
Z 
rmrf 1.00             
smb 0.01 1.00            
hml 0.05 -0.07 1.00           
umd -0.15 -0.08 -0.50 1.00          
smb_CPZ -0.08 0.92 0.01 -0.09 1.00         
hml_CPZ 0.11 0.04 0.88 -0.43 0.11 1.00        
umd_CPZ -0.12 -0.12 -0.46 0.97 -0.13 -0.40 1.00       
hmls -0.05 0.00 0.75 -0.44 0.08 0.56 -0.41 1.00      
hmlb 0.11 -0.02 0.83 -0.39 0.04 0.97 -0.36 0.43 1.00     
MMB_CPZ 0.17 0.85 0.13 -0.26 0.79 0.25 -0.27 0.22 0.15 1.00    
SMM_CPZ -0.33 0.45 -0.14 0.18 0.66 -0.12 0.13 -0.14 -0.12 0.05 1.00   
BHML_CPZ 0.09 -0.04 0.79 -0.34 0.03 0.95 -0.32 0.40 0.98 0.11 -0.09 1.00  
SHML_CPZ -0.08 -0.16 0.67 -0.38 -0.09 0.44 -0.32 0.62 0.35 -0.02 -0.12 0.33 1.00 
 
The Table reports the correlations between alternative definitions of the Fama-French and Cahart (momentum) factors.  Rmrf is the market risk 
premium, smb, hml and umd are as defined as in the text and on Ken French‟s website, with breakpoints formed using the largest 350 UK firms.  
Smb_CPZ, hml_CPZ and umd_CPZ are formed using the market capitalisations of the intersecting size and book-to-market (BTM), and size and 
momentum portfolios as described in Cremers et al. (2010).  hmls and hmlb are decompositions of the hml factor as in Zhang (2008), whilst 
MMB_CPZ is the mid-cap minus large cap factor, SMM_CPZ is the small cap minus mid-cap factor, and BHML_CPZ and SHML_CPZ are the 
decompositions of the hml_CPZ portfolio, all as described in Cremers et al. (2010).   
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Table 3: Summary statistics for the 5 x 5 Value-Weighted Size and book-to-market portfolios, October 1980 to December 2010 
stats SL S2 S3 S4 SH S2L S22 S23 S24 S2H M3L M32 M33 
mean 1.17% 1.06% 1.25% 1.44% 1.47% 0.88% 1.00% 1.09% 1.28% 1.30% 0.94% 0.93% 1.21% 
sd 6.71% 6.03% 5.18% 5.31% 5.28% 6.92% 5.95% 5.68% 6.14% 6.26% 7.12% 6.03% 5.89% 
skewness -63.06% -20.29% -42.93% -44.18% -27.47% -48.69% -97.53% -30.07% -36.59% 32.75% -89.72% -90.51% -115.48% 
max 26.44% 28.42% 23.08% 25.71% 25.85% 29.44% 16.92% 26.86% 21.95% 39.35% 33.38% 14.99% 13.75% 
min -32.75% -24.33% -20.73% -22.19% -22.53% -28.07% -26.83% -22.30% -26.43% -22.45% -34.23% -28.35% -32.08% 
median 1.73% 1.40% 1.49% 1.76% 1.57% 1.51% 1.27% 1.22% 1.61% 1.64% 1.44% 1.46% 1.77% 
kurtosis 6.69 5.82 5.87 6.24 6.05 5.42 5.93 5.36 5.17 8.64 7.76 5.31 7.41 
 
stats M34 M3H B4L B42 B43 B44 B4H BL B2 B3 B4 BH 
mean 1.14% 1.64% 1.08% 1.09% 1.29% 1.39% 1.49% 0.95% 0.90% 1.11% 1.35% 1.29% 
sd 6.10% 6.86% 6.39% 5.82% 5.73% 6.53% 6.60% 4.98% 5.13% 5.48% 5.52% 5.70% 
skewness -47.83% 22.64% -44.01% -84.94% -69.59% -34.82% -54.69% -110.80% -88.89% -59.34% -95.05% -38.59% 
max 20.15% 43.16% 33.45% 22.16% 19.39% 28.85% 26.15% 13.56% 16.55% 16.41% 17.49% 20.73% 
min -26.06% -27.64% -32.85% -31.94% -27.84% -28.32% -32.60% -34.35% -28.91% -23.84% -30.99% -20.00% 
median 1.67% 1.81% 1.70% 1.18% 1.30% 1.80% 1.74% 1.12% 1.27% 1.25% 1.57% 1.74% 
kurtosis 4.73 8.04 8.19 7.09 5.88 5.24 6.05 9.67 6.45 5.02 7.38 4.57 
These are 25 (5x5) intersecting size and book to market (BTM) portfolios for the “350 groups”– 5 size portfolios, with 4  portfolios formed from 
the largest 350 firms + 1 portfolio formed from the rest, and 5 BTM portfolios – with breakpoints based on the largest 350 firms. The first 
character denotes size, the second the BTM category, so for example SL denotes small – low BTM, S2 denotes size and second lowest BTM 
category, whilst B4 denotes big and fourth highest BTM category, and BH denotes big and high BTM.  However, outside the smallest and 
largest categories, we use three characters, so that, for example, M34 denotes the middle (third) size portfolio and the fourth largest book to 
market portfolio. Statistics reported are the mean, standard deviation (SD), skewness, maximum (max), minimum (min), median (p50), and 
kurtosis.  
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  Table 4: Summary statistics for the 3 x 3 x 3 size, book-to-market and momentum portfolios, October 1980-December 2010. 
 
stats SGL SGM SGH SML SMM SMH SVL SVM SVH MGL MGM MGH MML MMM 
mean 0.80% 0.98% 1.27% 1.29% 1.33% 1.55% 2.17% 1.43% 1.72% 0.97% 0.79% 0.99% 1.04% 1.24% 
sd 6.78% 5.31% 6.16% 6.77% 5.45% 5.96% 8.98% 6.10% 5.21% 6.53% 6.02% 7.14% 6.06% 5.52% 
skewness 1.09 -0.60 -0.71 -0.35 -0.17 1.82 1.76 0.24 -0.34 -0.12 -1.05 -1.23 -0.49 -0.52 
max 54.69% 19.77% 29.44% 31.50% 33.79% 58.37% 62.59% 40.18% 22.29% 29.94% 17.36% 29.71% 21.88% 21.19% 
min -24.65% -24.65% -31.42% -36.50% -24.74% -21.71% -23.51% -21.81% -21.45% -25.43% -30.51% -39.03% -27.62% -26.62% 
median 0.87% 1.22% 1.78% 1.10% 1.76% 1.87% 1.64% 1.63% 1.86% 1.12% 1.10% 1.79% 1.42% 1.31% 
kurtosis 14.46 5.91 7.16 7.03 8.97 26.22 13.95 8.33 5.43 5.29 6.57 7.88 5.22 5.44 
 
stats MMH MVL MVM MVH BGL BGM BGH BML BMM BMH BVL BVM BVH 
mean 1.22% 1.39% 1.23% 1.42% 0.84% 0.91% 1.05% 1.04% 0.98% 1.14% 1.27% 1.32% 1.43% 
sd 6.50% 9.12% 6.33% 6.26% 5.25% 5.06% 5.98% 6.17% 5.10% 6.38% 6.43% 5.82% 5.62% 
skewness -0.98 3.25 -0.13 -0.68 -0.68 -0.59 -1.45 -0.37 -0.80 -1.09 -0.40 -0.26 -0.85 
max 31.29% 97.21% 33.13% 24.10% 16.67% 16.63% 13.67% 22.69% 16.29% 18.70% 23.33% 24.35% 21.59% 
min -35.56% -27.40% -24.27% -27.62% -29.00% -26.16% -37.32% -23.08% -29.52% -29.36% -21.08% -23.58% -28.42% 
median 1.72% 1.15% 1.53% 2.02% 0.97% 1.14% 1.46% 1.69% 1.30% 1.50% 1.69% 1.55% 1.57% 
kurtosis 8.47 36.85 5.66 5.82 5.97 5.66 8.90 4.32 6.92 6.59 4.49 4.74 6.85 
The Tables show the 27 (3x3x3) portfolios, sequentially sorted on size, book-to-market (BTM) and momentum.  The three size portfolios are 
two portfolios formed from the largest 250 firms plus one group from the remainder.  Then within each size group we create three BTM groups. 
Finally, from within each of these 9 portfolios we form 3 momentum groups.   The first letter denotes size (Small, S; Medium, M; Large, L), the 
second the BTM category (Low or “Glamour”, G; Medium, M; High, or “value”, V), and the third momentum (Low, L; Medium, M; High, H).  
Statistics reported are the mean, standard deviation (SD), skewness, maximum (max), minimum (min), median (p50), and kurtosis.  
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Table 5: Summary statistics for the 25 Value-Weighted prior 12-month standard deviation portfolios, October 1980 to December 2010 
 
stats SD1 SD2 SD3 SD4 SD5 SD6 SD7 SD8 SD9 SD10 SD11 SD12 SD13 
mean 1.24% 1.40% 1.20% 0.93% 1.32% 1.08% 1.21% 0.94% 1.02% 1.61% 1.29% 1.03% 1.26% 
sd 4.78% 4.60% 4.91% 5.32% 5.09% 5.40% 4.90% 6.10% 5.87% 5.88% 5.77% 6.04% 6.06% 
skewness -0.19 -0.49 -0.91 -0.78 -0.59 -0.72 -0.47 -0.86 -1.05 -0.81 -0.34 -0.49 -0.47 
max 19.52% 18.08% 15.63% 15.61% 19.30% 19.53% 16.39% 17.82% 20.49% 26.44% 19.93% 25.74% 21.92% 
min -19.93% -23.24% -30.36% -30.58% -24.48% -22.51% -19.91% -32.66% -30.68% -28.99% -27.78% -27.16% -26.42% 
median 1.68% 1.45% 1.55% 1.24% 1.67% 1.26% 1.34% 1.31% 1.56% 1.78% 1.66% 1.49% 1.84% 
kurtosis 4.92 6.50 7.95 6.56 5.21 4.98 4.68 6.29 7.22 7.11 5.20 6.27 4.93 
 
stats SD14 SD15 SD16 SD17 SD18 SD19 SD20 SD21 SD22 SD23 SD24 SD25 
mean 1.25% 1.09% 1.05% 0.94% 1.14% 1.23% 1.60% 1.37% 1.07% 1.13% 1.40% 0.78% 
sd 6.53% 6.47% 6.30% 7.01% 6.96% 7.29% 7.73% 7.29% 7.82% 9.34% 8.32% 11.30% 
skewness -1.09 -0.34 -0.60 -0.45 -0.62 -0.61 -0.03 -0.44 0.25 0.28 -0.07 0.68 
max 17.51% 25.79% 20.67% 20.22% 23.64% 21.91% 36.81% 22.49% 44.30% 45.23% 37.48% 64.56% 
min -37.40% -32.27% -33.48% -26.78% -31.07% -33.58% -32.63% -25.73% -23.62% -27.74% -29.23% -40.75% 
median 1.74% 1.39% 1.52% 1.43% 1.12% 1.27% 1.67% 1.43% 1.18% 1.55% 1.76% 0.69% 
kurtosis 7.10 5.74 5.68 4.02 5.32 5.32 5.42 4.39 5.83 5.63 4.94 9.16 
These are 25 portfolios of firms ranked on their prior 12-month standard deviation of returns. SD1 is the portfolio with the lowest prior standard 
deviation, SD25 the portfolio with the highest. Statistics reported are the mean, standard deviation (SD), skewness, maximum (max), minimum 
(min), median (p50), and kurtosis.  
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Table 6: GRS Test Results for the Size and B/M Portfolios: 
Panel A. Basic Models 
Basic FF Basic Carhart 
P
o
rtfo
lio
s 
rm
rf 
sm
b
 
h
m
l 
_co
n
s 
rm
rf 
sm
b
 
h
m
l 
u
m
d
 
_co
n
s 
SL 
0.99 1.09 -0.37 0.00 1.00 1.10 -0.32 0.09 0.00 
29.12 21.96 -7.93 0.59 29.22 22.11 -5.87 1.99 0.02 
S2 
0.83 1.07 -0.16 0.00 0.83 1.07 -0.17 -0.02 0.00 
24.91 22.05 -3.46 0.02 24.56 21.75 -3.20 -0.43 0.14 
S3 
0.79 0.91 0.05 0.00 0.79 0.91 0.06 0.01 0.00 
33.26 26.48 1.59 1.50 32.93 26.24 1.57 0.39 1.33 
S4 
0.83 0.90 0.27 0.00 0.83 0.90 0.29 0.03 0.00 
35.63 26.76 8.50 2.52 35.42 26.65 7.87 1.05 2.14 
SH 
0.81 0.87 0.43 0.00 0.81 0.87 0.42 -0.01 0.00 
39.07 28.96 15.01 2.71 38.55 28.57 12.66 -0.54 2.75 
S2L 
1.03 0.92 -0.63 0.00 1.04 0.92 -0.59 0.06 0.00 
27.27 16.68 -12.02 -0.64 27.18 16.69 -9.77 1.20 -0.95 
S22 
0.94 0.81 -0.01 0.00 0.93 0.81 -0.03 
-0.04 0.00 
27.15 16.24 -0.15 -0.79 26.74 15.95 -0.60 -0.92 -0.51 
S23 
0.89 0.75 0.19 0.00 0.88 0.74 0.16 -0.04 0.00 
26.75 15.62 4.15 -0.47 26.33 15.33 3.08 -1.00 -0.18 
S24 
0.98 0.82 0.25 0.00 0.97 0.82 0.24 -0.02 0.00 
28.67 16.70 5.39 0.32 28.28 16.46 4.42 -0.44 0.43 
S2H 
0.97 0.84 0.58 0.00 0.96 0.83 0.55 -0.06 0.00 
31.46 18.85 13.73 -0.19 30.99 18.49 11.17 -1.37 0.20 
M3L 
1.12 0.86 -0.66 0.00 1.12 0.85 -0.68 -0.04 0.00 
30.73 16.26 -13.09 -0.49 30.28 15.97 -11.72 -0.86 -0.23 
M32 
1.07 0.59 -0.07 0.00 1.06 0.57 -0.12 -0.08 0.00 
33.95 12.88 -1.58 -1.55 33.46 12.52 -2.39 -2.02 -0.94 
M33 
1.01 0.63 0.16 0.00 1.01 0.63 0.16 0.00 0.00 
31.98 13.65 3.57 0.03 31.61 13.50 3.10 0.04 0.02 
M34 
1.03 0.57 0.46 0.00 1.01 0.55 0.39 -0.11 0.00 
31.89 12.19 10.27 -1.02 31.44 11.81 7.66 -2.50 -0.30 
M3H 
1.05 0.85 0.67 0.00 1.04 0.83 0.60 -0.11 0.00 
28.94 16.12 13.35 1.44 28.49 15.74 10.42 -2.30 2.03 
B4L 
1.09 0.51 -0.57 0.00 1.10 0.51 -0.55 0.03 0.00 
32.47 10.36 -12.24 0.44 32.23 10.35 -10.17 0.76 0.21 
B42 
1.06 0.41 -0.04 0.00 1.05 0.41 -0.07 -0.04 0.00 
33.62 9.09 -1.02 -0.36 33.14 8.87 -1.34 -0.91 -0.10 
B43 
1.04 0.37 0.22 0.00 1.03 0.36 0.20 -0.03 0.00 
33.68 8.19 5.09 0.55 33.20 7.99 3.97 -0.84 0.76 
B44 
1.14 0.49 0.37 0.00 1.13 0.48 0.30 -0.11 0.00 
32.62 9.70 7.66 0.42 32.16 9.33 5.42 -2.43 1.07 
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B4H 
1.11 0.50 0.61 0.00 1.09 0.47 0.52 -0.15 0.00 
31.99 9.88 12.75 0.69 31.62 9.46 9.50 -3.26 1.58 
BL 
0.90 -0.28 -0.50 0.00 0.89 -0.29 -0.53 -0.05 0.00 
38.32 -8.35 -15.54 0.80 37.78 -8.48 -14.17 -1.46 1.18 
B2 
0.96 -0.16 -0.15 0.00 0.96 -0.16 -0.16 -0.02 0.00 
34.66 -3.99 -3.98 -0.87 34.21 -4.01 -3.64 -0.42 -0.72 
B3 
1.05 -0.01 0.00 0.00 1.05 0.00 0.03 0.05 0.00 
37.28 -0.30 0.00 -0.06 37.15 -0.09 0.72 1.43 -0.45 
B4 
1.02 -0.16 0.23 0.00 1.03 -0.14 0.28 0.08 0.00 
34.65 -3.67 5.61 1.38 34.78 -3.35 5.94 2.14 0.74 
BH 
0.89 -0.35 0.52 0.00 0.89 -0.35 0.50 -0.04 0.00 
25.13 -6.72 10.68 0.74 24.73 -6.77 8.76 -0.90 0.96 
GRS 1.27       1.22         
p 0.18       0.22         
Mean R2 0.78    0.78     
The Table reports the results of the first-stage regression tests of the returns of the 25 
intersecting portfolios sorted size and book-to-market (BTM) on the Fama-French and 
Carhart factors, together with the result of the GRS F-test and the p-value for the 
rejection of the null hypothesis that all the intercept (_cons) terms are jointly zero.  
For the portfolios, the first character denotes size, the second the BTM category, so 
for example SL denotes small – low BTM, S2 denotes size and second lowest BTM 
category, whilst B4 denotes big and fourth highest BTM category, and BH denotes 
big and high BTM category.  However, outside the smallest and largest categories, we 
use three characters, so that, for example, M34 denotes the middle (third) size 
portfolio and the fourth largest BTM portfolio. The factors are rmrf, the market risk 
premium, smb, hml and umd are factors as defined in the text and on Ken French‟s 
website, with breakpoints formed using the largest 350 UK firms.  For each of the 
portfolios the table reports two rows; with the coefficient in the top row and the 
corresponding t-statistic in the bottom row. 
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Table 6: GRS Test Results for the Size and B/M Portfolios:  
Panel B. Value-Weighted Factor Components Models. 
CPZ-FF CPZ-Carhart 
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SL 
1.08 0.91 -0.29 0.00 1.09 0.92 -0.23 0.10 0.00 
31.04 23.36 -6.52 -0.57 31.48 23.75 -5.01 2.85 -1.16 
S2 
0.91 0.89 -0.16 0.00 0.91 0.89 -0.16 0.01 0.00 
28.90 25.21 -4.11 -1.07 28.74 25.07 -3.72 0.19 -1.08 
S3 
0.85 0.74 -0.02 0.00 0.85 0.74 -0.02 0.00 0.00 
39.43 30.58 -0.85 0.52 39.20 30.40 -0.74 0.10 0.49 
S4 
0.88 0.68 0.15 0.00 0.88 0.68 0.14 -0.01 0.00 
37.10 25.85 4.90 1.67 36.85 25.66 4.40 -0.33 1.70 
SH 
0.86 0.68 0.25 0.00 0.85 0.67 0.22 -0.06 0.00 
40.87 28.75 9.52 1.89 40.82 28.63 7.80 -2.90 2.47 
S2L 
1.11 0.73 -0.43 0.00 1.12 0.75 -0.35 0.15 0.00 
25.24 14.95 -7.72 -1.44 25.76 15.39 -6.01 3.23 -2.10 
S22 
 
0.99 0.59 -0.03 0.00 0.98 0.59 -0.04 -0.02 0.00 
27.00 14.37 -0.72 -1.30 26.79 14.23 -0.89 -0.58 -1.15 
S23 
 
0.93 0.50 0.02 0.00 0.92 0.49 -0.02 -0.09 0.00 
25.53 12.27 0.47 -0.63 25.34 12.06 -0.41 -2.24 -0.15 
S24 
 
1.02 0.58 0.09 0.00 1.02 0.57 0.07 -0.06 0.00 
27.82 14.06 2.05 -0.02 27.59 13.87 1.30 -1.57 0.30 
S2H 
 
1.00 0.53 0.32 0.00 0.99 0.52 0.25 -0.15 0.00 
26.66 12.66 6.73 -0.26 26.64 12.46 4.93 -3.70 0.52 
M3L 
 
1.18 0.60 -0.43 0.00 1.19 0.60 -0.39 0.07 0.00 
25.72 11.61 -7.36 -1.10 25.77 11.70 -6.28 1.41 -1.38 
M32 
 
1.10 0.35 -0.02 0.00 1.09 0.35 -0.04 -0.03 0.00 
31.52 9.07 -0.53 -1.81 31.28 8.94 -0.84 -0.92 -1.58 
M33 
 
1.04 0.38 0.09 0.00 1.04 0.38 0.08 -0.03 0.00 
30.07 9.93 2.16 -0.24 29.84 9.81 1.74 -0.68 -0.09 
M34 
 
1.05 0.32 0.27 0.00 1.03 0.30 0.19 -0.16 0.00 
28.40 7.69 5.71 -0.88 28.49 7.41 3.83 -4.15 -0.02 
M3H 
1.08 0.49 0.37 0.00 1.06 0.47 0.26 -0.21 0.00 
24.18 9.74 6.48 1.21 24.27 9.50 4.45 -4.48 2.15 
B4L 
 
1.14 0.42 -0.44 0.00 1.15 0.43 -0.39 0.10 0.00 
30.63 10.05 -9.26 -0.19 30.97 10.33 -7.67 2.56 -0.72 
B42 
 
1.09 0.29 -0.10 0.00 1.08 0.29 -0.13 -0.06 0.00 
33.57 8.05 -2.37 -0.56 33.34 7.87 -2.88 -1.79 -0.17 
B43 
 
1.05 0.21 0.16 0.00 1.04 0.21 0.13 -0.05 0.00 
32.59 5.95 3.86 0.40 32.35 5.79 3.05 -1.39 0.68 
B44 
 
1.16 0.29 0.26 0.00 1.15 0.28 0.20 -0.13 0.00 
30.97 6.94 5.55 0.28 30.91 6.68 3.98 -3.21 0.95 
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B4H 
 
1.11 0.27 0.47 0.00 1.10 0.25 0.38 -0.18 0.00 
29.42 6.45 9.80 0.58 29.65 6.15 7.56 -4.64 1.55 
BL 
0.91 -0.15 -0.52 0.00 0.91 -0.15 -0.52 0.00 0.00 
42.52 -6.07 -19.00 1.27 42.24 -6.06 -17.64 -0.21 1.29 
B2 
0.96 -0.11 -0.16 0.00 0.96 -0.11 -0.17 -0.01 0.00 
34.68 -3.42 -4.57 -0.69 34.44 -3.44 -4.37 -0.40 -0.59 
B3 
1.04 -0.02 0.04 0.00 1.05 -0.02 0.07 0.06 0.00 
36.85 -0.74 1.12 -0.12 37.01 -0.55 1.77 1.92 -0.52 
B4 
0.99 -0.17 0.28 0.00 0.99 -0.17 0.31 0.07 0.00 
34.68 -5.44 7.78 1.53 34.98 -5.22 8.16 2.41 1.00 
BH 
0.83 -0.27 0.66 0.00 0.83 -0.27 0.65 -0.02 0.00 
25.75 -7.54 16.16 0.74 25.55 -7.55 14.72 -0.57 0.84 
GRS 1.01       1.09         
p 0.45       0.35         
Mean R2 0.75    0.76     
The Table reports the results of the first-stage regression tests of the returns of the 25 
intersecting portfolios sorted size and book-to-market (BTM) on the Fama-French and 
Carhart factors, together with the result of the GRS F-test and the p-value for the 
rejection of the null hypothesis that all the intercept (_cons) terms are jointly zero.  
For the portfolios, the first character denotes size, the second the BTM category, so 
for example SL denotes small – low BTM, S2 denotes size and second lowest BTM 
category, whilst B4 denotes big and fourth highest BTM category, and BH denotes 
big and high BTM category.  However, outside the smallest and largest categories, we 
use three characters, so that, for example, M34 denotes the middle (third) size 
portfolio and the fourth largest BTM portfolio.  The factors are rmrf, the market risk 
premium, smb_CPZ, hml_CPZ and umd_CPZ, formed using the market 
capitalisations of the intersecting size and BTM, and size and momentum portfolios as 
described in Cremers et al. (2010).  For each of the portfolios the table reports two 
rows; with the coefficient in the top row and the corresponding t-statistic in the 
bottom row. 
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Table 6: GRS Test Results for the Size and B/M Portfolios: 
Panel C. Decomposed Factor Models  
Zhang Decomposition CPZ-Decomposition 
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SL 
0.98 1.13 -0.21 0.03 0.12 0.00 1.04 0.77 0.92 0.00 -0.49 0.01 0.00 
28.06 22.75 -5.43 0.55 2.59 -0.30 34.34 17.72 16.92 0.03 -14.33 0.26 0.10 
S2 
0.82 1.08 -0.14 0.03 -0.01 0.00 0.88 0.77 0.91 0.02 -0.37 -0.07 0.00 
23.87 22.30 -3.67 0.56 -0.32 0.05 29.47 17.82 17.02 0.62 -11.07 -2.33 -0.08 
S3 
0.79 0.91 0.03 0.03 0.02 0.00 0.85 0.74 0.74 -0.01 0.02 0.01 0.00 
32.53 26.33 1.09 1.06 0.51 1.28 36.28 21.80 17.57 -0.45 0.59 0.43 0.33 
S4 
0.83 0.88 0.09 0.13 0.01 0.00 0.89 0.75 0.66 0.06 0.15 0.02 0.00 
33.89 25.39 3.24 3.94 0.18 2.43 35.58 20.91 14.79 2.08 5.35 0.83 1.27 
SH 
0.82 0.84 0.19 0.14 -0.03 0.00 0.91 0.71 0.76 0.07 0.32 -0.02 0.00 
37.10 26.70 7.95 4.82 -1.12 2.95 50.75 27.45 23.83 3.54 15.74 -0.95 1.34 
S2L 
1.01 0.98 -0.35 -0.03 0.10 0.00 1.04 0.68 0.63 -0.09 -0.47 0.09 0.00 
25.40 17.35 -8.00 -0.65 1.99 -1.36 24.22 10.94 8.11 -1.74 -9.61 2.08 -1.33 
S22 
0.92 0.81 -0.08 0.05 -0.05 0.00 0.95 0.69 0.43 -0.04 0.02 0.01 0.00 
26.16 16.20 -2.05 1.11 -1.16 -0.44 24.12 12.14 6.13 -0.79 0.47 0.31 -1.18 
S23 
0.89 0.73 0.10 -0.04 -0.07 0.00 0.88 0.67 0.28 -0.08 0.12 -0.03 0.00 
26.22 15.03 2.77 -0.80 -1.55 0.10 23.23 12.13 4.05 -1.76 2.74 -0.68 -0.35 
S24 
0.98 0.80 0.12 0.02 -0.05 0.00 0.98 0.76 0.37 -0.01 0.16 0.00 0.00 
27.86 15.95 3.13 0.40 -1.03 0.70 25.71 13.72 5.37 -0.31 3.68 0.08 0.03 
S2H 
0.99 0.79 0.35 0.07 -0.06 0.00 0.94 0.82 0.21 0.07 0.25 -0.06 0.00 
31.81 17.78 10.27 1.72 -1.60 0.40 25.64 15.47 3.16 1.62 6.10 -1.67 0.29 
M3L 
1.09 0.91 -0.36 -0.07 0.02 0.00 1.02 0.80 0.10 -0.16 -0.45 0.07 0.00 
27.55 16.31 -8.30 -1.41 0.36 -0.80 23.26 12.52 1.27 -3.11 -9.16 1.57 -0.43 
M32 
1.04 0.59 -0.14 0.08 -0.08 0.00 0.99 0.60 -0.05 -0.01 -0.08 0.02 0.00 
32.86 13.07 -4.05 1.84 -2.04 -1.03 28.34 11.99 -0.86 -0.24 -1.92 0.44 -1.24 
M33 
1.00 0.61 -0.01 0.11 -0.03 0.00 0.96 0.65 0.02 0.03 0.05 0.04 0.00 
30.76 13.26 -0.15 2.49 -0.65 0.28 27.31 12.87 0.33 0.81 1.24 1.01 0.07 
M34 
1.03 0.52 0.22 0.04 -0.13 0.00 0.97 0.64 -0.08 0.01 0.24 -0.07 0.00 
31.05 10.98 6.02 0.97 -3.08 0.02 27.87 12.78 -1.26 0.36 6.08 -1.90 -0.24 
M3H 
1.09 0.78 0.50 -0.01 -0.09 0.00 0.98 0.88 0.01 0.03 0.28 -0.11 0.00 
32.14 16.25 13.35 -0.28 -2.08 2.20 23.20 14.35 0.08 0.66 5.79 -2.48 2.27 
B4L 
1.09 0.56 -0.21 -0.17 0.08 0.00 1.05 0.51 0.15 -0.17 -0.30 0.11 0.00 
29.89 10.76 -5.35 -3.41 1.79 -0.28 27.25 9.07 2.16 -3.91 -6.84 2.83 -0.14 
B42 
1.06 0.41 0.02 -0.10 -0.03 0.00 0.98 0.54 -0.12 -0.10 -0.03 0.01 0.00 
33.06 9.03 0.69 -2.24 -0.76 -0.13 30.61 11.76 -2.11 -2.84 -0.70 0.16 0.07 
B43 
1.03 0.35 0.05 0.11 -0.05 0.00 0.97 0.49 -0.14 0.05 0.12 0.02 0.00 
32.48 7.69 1.35 2.64 -1.19 0.89 30.60 10.77 -2.48 1.37 3.24 0.75 0.74 
B44 
1.13 0.45 0.10 0.15 -0.13 0.00 1.05 0.64 -0.18 0.08 0.12 -0.05 0.00 
31.40 8.87 2.42 3.07 -2.82 1.24 29.19 12.35 -2.76 1.92 2.90 -1.31 1.23 
B4H 1.09 0.44 0.14 0.28 -0.18 0.00 1.01 0.66 -0.19 0.17 0.22 -0.10 0.00 
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30.19 8.52 3.55 5.76 -3.98 1.86 28.63 12.85 -2.99 4.29 5.62 -2.64 1.76 
BL 
0.93 -0.26 0.04 -0.53 0.00 0.00 0.93 -0.23 -0.09 -0.47 0.06 0.03 0.00 
45.08 -8.86 1.72 -19.31 0.09 0.82 41.07 -7.15 -2.11 -18.15 2.18 1.13 0.44 
B2 
0.97 -0.15 0.02 -0.18 -0.01 0.00 0.96 -0.12 -0.11 -0.17 0.01 -0.01 0.00 
34.65 -3.88 0.52 -4.81 -0.14 -0.80 32.18 -2.82 -2.12 -5.05 0.15 -0.26 -0.64 
B3 
1.05 0.00 -0.01 0.06 0.06 0.00 1.06 -0.05 0.03 0.07 -0.02 0.04 0.00 
36.56 -0.10 -0.33 1.65 1.54 -0.52 34.55 -1.07 0.52 1.87 -0.69 1.29 -0.39 
B4 
1.01 -0.16 -0.02 0.28 0.06 0.00 1.01 -0.14 -0.12 0.26 0.06 0.07 0.00 
34.40 -3.84 -0.71 7.18 1.51 0.97 33.02 -3.28 -2.22 7.46 1.79 2.11 0.95 
BH 
0.84 -0.37 -0.05 0.65 -0.04 0.00 0.86 -0.36 -0.08 0.66 -0.10 -0.09 0.00 
28.02 -8.69 -1.62 16.22 -1.04 0.96 27.09 -7.74 -1.38 18.04 -2.69 -2.92 1.42 
GRS 1.14           0.97             
P 0.30           0.51             
Mean R2 0.79           0.80             
The Table reports the results of the first-stage regression tests of the returns of the 25 
intersecting portfolios sorted size and book-to-market (BTM) on the Fama-French and 
Carhart factors, together with the result of the GRS F-test and the p-value for the 
rejection of the null hypothesis that all the intercept (_cons) terms are jointly zero.  
For the portfolios, the first character denotes size, the second the BTM category, so 
for example SL denotes small – low BTM, S2 denotes size and second lowest BTM 
category, whilst B4 denotes big and fourth highest BTM category, and BH denotes 
big and high BTM category.  However, outside the smallest and largest categories, we 
use three characters, so that, for example, M34 denotes the middle (third) size 
portfolio and the fourth largest BTM portfolio. The factors are rmrf, the market risk 
premium, hmls and hmlb, the decompositions of the hml factor as in Zhang (2008), 
MMB_CPZ, the mid-cap minus large cap factor, SMM_CPZ, the small cap minus mid-
cap factor, BHML_CPZ and SHML_CPZ the decompositions of the hml_CPZ 
portfolio, all as described in Cremers et al. (2010). For each of the portfolios the table 
reports two rows; with the coefficient in the top row and the corresponding t-statistic 
in the bottom row. 
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Table 7: GRS Test Results for the Size x B/M x Momentum Portfolios:  
Panel A. Basic Models 
Basic FF Basic Carhart 
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SGL 
 
0.92 1.29 0.14 0.00 0.89 1.24 -0.03 -0.28 0.00 
25.43 24.50 2.79 -2.39 25.56 24.62 -0.60 -6.17 -0.71 
SGM 
 
0.82 0.87 -0.02 0.00 0.82 0.88 0.00 0.02 0.00 
30.27 22.37 -0.51 -0.71 30.03 22.22 -0.11 0.64 -0.86 
SGH 
 
0.95 1.02 -0.11 0.00 0.95 1.02 -0.09 0.04 0.00 
30.64 22.71 -2.70 1.03 30.48 22.64 -1.81 1.03 0.70 
SML 
 
0.91 1.08 0.44 0.00 0.90 1.07 0.38 -0.09 0.00 
21.56 17.77 7.57 0.08 21.15 17.40 5.69 -1.69 0.54 
SMM 
 
0.80 0.90 0.33 0.00 0.80 0.89 0.31 -0.02 0.00 
28.60 21.97 8.42 1.19 28.20 21.66 6.97 -0.57 1.30 
SMH 
 
0.81 0.96 0.38 0.00 0.81 0.96 0.38 -0.01 0.00 
22.69 18.51 7.74 2.13 22.40 18.27 6.56 -0.21 2.10 
SVL 
 
1.02 1.29 0.85 0.01 0.99 1.25 0.67 -0.29 0.01 
15.80 13.76 9.49 2.28 15.38 13.35 6.55 -3.49 3.19 
SVM 
 
0.86 0.89 0.53 0.00 0.85 0.87 0.45 -0.13 0.00 
24.65 17.61 10.88 1.04 24.24 17.21 8.06 -2.80 1.78 
SVH 
 
0.77 0.73 0.33 0.01 0.78 0.74 0.38 0.08 0.00 
24.69 16.17 7.58 3.94 24.82 16.36 7.58 2.00 3.25 
MGL 
 
1.06 0.89 -0.32 0.00 1.05 0.88 -0.35 -0.05 0.00 
31.27 18.12 -6.84 -0.82 30.80 17.79 -6.49 -1.15 -0.47 
MGM 
 
1.03 0.66 -0.09 0.00 1.01 0.64 -0.20 -0.18 0.00 
31.72 14.11 -1.97 -2.28 31.55 13.70 -3.93 -4.33 -1.05 
MGH 
 
1.13 0.82 -0.55 0.00 1.13 0.82 -0.55 -0.01 0.00 
28.22 14.11 -9.95 -0.39 27.88 13.94 -8.64 -0.13 -0.34 
MML 
 
0.93 0.77 0.31 0.00 0.91 0.74 0.20 -0.18 0.00 
25.60 14.59 6.19 -1.05 25.28 14.18 3.49 -3.87 0.04 
MMM 
 
0.94 0.64 0.17 0.00 0.93 0.63 0.15 -0.04 0.00 
32.46 15.25 4.28 0.52 31.98 14.96 3.19 -1.00 0.77 
MMH 
 
1.09 0.72 0.19 0.00 1.08 0.71 0.14 -0.09 0.00 
30.00 13.80 3.82 -0.24 29.53 13.45 2.37 -1.87 0.28 
MVL 
 
1.21 1.35 1.01 0.00 1.15 1.27 0.69 -0.52 0.00 
23.42 18.12 14.26 -1.00 24.11 18.42 9.20 -8.34 1.26 
MVM 
 
1.01 0.76 0.58 0.00 1.01 0.76 0.55 -0.04 0.00 
32.27 16.81 13.43 -0.78 31.79 16.51 11.08 -1.00 -0.47 
MVH 
 
1.04 0.64 0.40 0.00 1.03 0.64 0.39 -0.02 0.00 
29.76 12.66 8.36 0.77 29.35 12.45 6.95 -0.51 0.88 
BGL 
 
0.92 -0.13 -0.12 0.00 0.89 -0.17 -0.27 -0.24 0.00 
26.66 -2.56 -2.63 -0.99 26.67 -3.41 -5.15 -5.53 0.54 
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BGM 
 
0.88 -0.24 -0.23 0.00 0.87 -0.25 -0.28 -0.08 0.00 
27.38 -5.19 -5.26 -0.13 26.92 -5.44 -5.56 -1.99 0.42 
BGH 
 
1.00 0.00 -0.63 0.00 1.01 0.01 -0.61 0.05 0.00 
27.97 0.06 -12.82 0.91 27.82 0.20 -10.56 0.99 0.60 
BML 
 
1.12 0.08 0.21 0.00 1.10 0.04 0.08 -0.20 0.00 
31.18 1.46 4.20 -1.11 31.03 0.86 1.47 -4.45 0.13 
BMM 
 
0.95 0.00 -0.06 0.00 0.97 0.03 0.03 0.16 0.00 
33.64 0.04 -1.66 -0.48 34.80 0.67 0.79 4.46 -1.70 
BMH 
 
1.13 0.08 -0.06 0.00 1.13 0.08 -0.06 0.01 0.00 
27.87 1.37 -1.11 -0.05 27.56 1.37 -0.90 0.12 -0.08 
BVL 
 
1.04 0.18 0.71 0.00 1.02 0.15 0.60 -0.18 0.00 
28.07 3.27 13.89 -0.47 27.76 2.77 10.29 -3.77 0.58 
BVM 
 
1.03 0.13 0.45 0.00 1.02 0.12 0.39 -0.09 0.00 
33.14 2.92 10.43 0.42 32.67 2.59 7.90 -2.28 1.03 
BVH 
 
0.95 -0.22 0.23 0.00 0.96 -0.21 0.27 0.08 0.00 
25.78 -4.07 4.46 1.83 25.79 -3.82 4.65 1.57 1.33 
GRS 
2.23       1.75         
p 
0.00       0.01         
Mean R2 
0.73 
   
0.74 
    The Table reports the results of the first-stage regression tests of the returns of the 27 
sequentially sorted size, book-to-market (BTM) and momentum portfolios on the 
Fama-French and Carhart factors, together with the result of the GRS F-test and the p-
value for the rejection of the null hypothesis that all the intercept (_cons) terms are 
jointly zero.  For the portfolios, the first letter denotes size (Small, S; Medium, M; 
Large, L), the second the BTM category (Low or “Glamour”, G; Medium, M; High, 
or “value”, V), and the third momentum (Low, L; Medium, M; High, H) category.  
The factors are rmrf, the market risk premium, smb, hml and umd are as defined in the 
text and on Ken French‟s website, with breakpoints formed using the largest 350 UK 
firms.  For each of the portfolios the table reports two rows; with the coefficient in the 
top row and the corresponding t-statistic in the bottom row. 
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Table 7: GRS Test Results for the Size x B/M x Momentum Portfolios:  
Panel B. Value -Weighted Factor Components Models 
CPZ-FF CPZ-Carhart 
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SGL 
 
1.00 1.01 0.05 -0.01 0.98 0.98 -0.06 -0.22 0.00 
28.37 25.51 1.15 -3.44 29.09 26.08 -1.24 -6.23 -2.24 
SGM 
 
0.88 0.70 -0.06 0.00 0.88 0.70 -0.05 0.03 0.00 
33.58 24.03 -1.90 -1.68 33.51 24.00 -1.40 0.96 -1.85 
SGH 
 
1.02 0.82 -0.13 0.00 1.02 0.83 -0.11 0.05 0.00 
33.74 24.34 -3.46 0.04 33.79 24.41 -2.64 1.51 -0.27 
SML 
 
0.97 0.86 0.25 0.00 0.96 0.84 0.20 -0.11 0.00 
23.45 18.53 4.88 -0.50 23.27 18.33 3.58 -2.55 0.04 
SMM 
 
0.86 0.66 0.13 0.00 0.85 0.66 0.11 -0.06 0.00 
28.33 19.65 3.53 0.65 28.11 19.44 2.58 -1.85 1.02 
SMH 
 
0.87 0.72 0.14 0.00 0.86 0.71 0.10 -0.09 0.00 
22.90 16.89 2.95 1.67 22.70 16.68 1.91 -2.20 2.10 
SVL 
 
1.07 0.97 0.64 0.01 1.05 0.94 0.51 -0.27 0.01 
16.55 13.36 7.81 1.85 16.43 13.18 5.85 -4.03 2.69 
SVM 
 
0.91 0.69 0.33 0.00 0.89 0.67 0.25 -0.15 0.00 
25.34 17.10 7.26 0.56 25.37 16.99 5.30 -4.12 1.42 
SVH 
 
0.81 0.55 0.12 0.01 0.81 0.55 0.12 -0.01 0.01 
24.78 14.97 2.87 3.49 24.62 14.86 2.59 -0.17 3.45 
MGL 
 
1.12 0.65 -0.23 0.00 1.12 0.65 -0.22 0.03 0.00 
29.08 15.02 -4.75 -1.45 28.97 14.99 -4.16 0.62 -1.55 
MGM 
 
1.07 0.45 -0.06 0.00 1.06 0.43 -0.12 -0.11 0.00 
30.19 11.25 -1.40 -2.58 30.09 11.02 -2.45 -3.00 -1.93 
MGH 
 
1.19 0.59 -0.39 0.00 1.20 0.60 -0.36 0.07 0.00 
25.77 11.42 -6.68 -0.97 25.81 11.51 -5.67 1.35 -1.23 
MML 
 
0.97 0.51 0.20 0.00 0.95 0.49 0.12 -0.16 0.00 
24.59 11.52 3.99 -1.28 24.56 11.30 2.30 -3.85 -0.47 
MMM 
 
0.97 0.41 0.07 0.00 0.97 0.40 0.04 -0.06 0.00 
30.32 11.38 1.69 0.23 30.10 11.18 0.87 -1.85 0.61 
MMH 
 
1.12 0.44 0.05 0.00 1.11 0.43 0.00 -0.12 0.00 
27.97 9.78 1.07 -0.37 27.84 9.55 -0.09 -2.87 0.23 
MVL 
 
1.26 0.86 0.61 0.00 1.21 0.80 0.35 -0.54 0.00 
20.30 12.37 7.86 -0.97 21.48 12.73 4.62 -9.00 0.83 
MVM 
 
1.04 0.43 0.34 0.00 1.03 0.42 0.27 -0.13 0.00 
26.77 9.99 6.87 -0.64 26.66 9.76 5.26 -3.09 0.01 
MVH 
 
1.07 0.37 0.15 0.00 1.06 0.36 0.09 -0.13 0.00 
26.76 8.37 2.92 0.75 26.64 8.13 1.60 -2.98 1.37 
BGL 0.92 -0.09 -0.14 0.00 0.90 -0.11 -0.23 -0.18 0.00 
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26.65 -2.28 -3.27 -0.85 26.92 -2.84 -5.03 -5.04 0.19 
BGM 
 
0.88 -0.17 -0.29 0.00 0.87 -0.18 -0.33 -0.07 0.00 
28.58 -4.90 -7.57 0.25 28.37 -5.10 -7.83 -2.08 0.68 
BGH 
 
1.03 0.05 -0.54 0.00 1.04 0.06 -0.49 0.11 0.00 
27.60 1.20 -11.50 0.75 27.96 1.46 -9.72 2.66 0.19 
BML 
 
1.11 0.03 0.19 0.00 1.09 0.01 0.10 -0.18 0.00 
30.74 0.73 4.20 -1.13 31.07 0.27 2.16 -4.85 -0.13 
BMM 
 
0.95 -0.01 -0.05 0.00 0.97 0.00 0.02 0.14 0.00 
33.40 -0.31 -1.48 -0.47 34.70 0.15 0.40 4.77 -1.47 
BMH 
 
1.13 0.01 0.01 0.00 1.13 0.01 0.04 0.06 0.00 
27.46 0.18 0.24 -0.14 27.50 0.31 0.74 1.38 -0.43 
BVL 
 
1.01 0.07 0.71 0.00 1.00 0.05 0.63 -0.16 0.00 
28.77 1.83 16.07 -0.68 28.95 1.43 13.55 -4.48 0.25 
BVM 
 
1.02 0.03 0.39 0.00 1.01 0.02 0.34 -0.11 0.00 
31.87 0.94 9.70 0.45 31.83 0.63 7.85 -3.27 1.12 
BVH 
 
0.92 -0.22 0.27 0.00 0.92 -0.21 0.29 0.04 0.00 
25.21 -5.35 5.86 2.00 25.20 -5.22 5.85 1.10 1.73 
GRS 2.01       1.80         
p 
0.00       0.01         
Mean R2 
0.71 
   
0.72 
    The Table reports the results of the first-stage regression tests of the returns of the 27 
sequentially sorted size, book-to-market (BTM) and momentum portfolios on the 
Fama-French and Carhart factors, together with the result of the GRS F-test and the p-
value for the rejection of the null hypothesis that all the intercept (_cons) terms are 
jointly zero.  For the portfolios, the first letter denotes size (Small, S; Medium, M; 
Large, L), the second the BTM category (Low or “Glamour”, G; Medium, M; High, 
or “value”, V), and the third momentum (Low, L; Medium, M; High, H) category.  
The factors are rmrf, the market risk premium, smb_CPZ, hml_CPZ and umd_CPZ, 
formed using the market capitalisations of the intersecting size and BTM, and size and 
momentum portfolios as described in Cremers et al. (2010).  For each of the portfolios 
the table reports two rows; with the coefficient in the top row and the corresponding t-
statistic in the bottom row. 
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Table 7: GRS Test Results for the Size x B/M x Momentum Portfolios:  
Panel C. Decomposed Factor Models  
Zhang Decomposition CPZ-Decomposition 
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SGL 
0.89 1.25 -0.02 0.02 -0.27 0.00 0.95 0.97 0.94 0.00 -0.15 -0.25 0.00 
25.11 24.85 -0.39 0.45 -5.89 -0.84 26.65 18.82 14.59 0.08 -3.68 -6.80 -1.80 
SGM 
0.81 0.88 -0.06 0.05 0.01 0.00 0.88 0.68 0.72 0.00 -0.06 0.02 0.00 
29.42 22.50 -1.83 1.39 0.37 -0.79 30.95 16.56 14.14 -0.14 -1.76 0.65 -1.73 
SGH 
0.94 1.03 -0.09 0.05 0.05 0.00 1.00 0.76 0.83 0.01 -0.21 0.01 0.00 
29.80 23.09 -2.49 1.20 1.24 0.58 31.82 16.82 14.66 0.36 -5.90 0.40 0.27 
SML 
0.90 1.04 0.17 0.14 -0.11 0.00 1.00 0.89 0.91 0.06 0.29 -0.06 0.00 
20.87 16.90 3.56 2.35 -1.97 0.68 23.49 14.51 11.90 1.27 6.07 -1.49 -0.63 
SMM 
0.81 0.87 0.17 0.05 -0.04 0.00 0.87 0.74 0.65 0.00 0.25 -0.01 0.00 
27.86 20.86 5.28 1.26 -1.07 1.55 28.45 16.58 11.85 -0.12 7.14 -0.22 0.29 
SMH 
0.83 0.92 0.19 0.04 -0.04 0.00 0.89 0.76 0.72 0.00 0.22 -0.05 0.00 
22.09 17.42 4.75 0.81 -0.92 2.41 22.25 13.28 10.11 0.00 4.87 -1.12 1.60 
SVL 
0.98 1.20 0.19 0.42 -0.31 0.01 1.09 1.06 0.99 0.33 0.35 -0.22 0.01 
15.05 12.95 2.63 4.78 -3.75 3.28 16.20 10.85 8.15 4.28 4.55 -3.21 2.29 
SVM 
0.86 0.84 0.20 0.16 -0.15 0.00 0.94 0.70 0.76 0.12 0.28 -0.12 0.00 
23.78 16.40 4.96 3.39 -3.15 1.95 26.06 13.49 11.74 2.82 6.86 -3.16 0.74 
SVH 
0.80 0.71 0.23 0.02 0.06 0.01 0.85 0.63 0.56 -0.02 0.31 0.06 0.00 
24.97 15.64 6.64 0.57 1.52 3.50 25.82 13.29 9.56 -0.58 8.39 1.71 2.77 
MGL 
1.04 0.91 -0.18 -0.02 -0.01 0.00 1.00 0.86 0.23 -0.09 -0.23 0.06 0.00 
29.29 18.15 -4.58 -0.53 -0.27 -0.87 25.77 15.38 3.27 -2.02 -5.26 1.44 -0.96 
MGM 
0.99 0.65 -0.18 0.04 -0.18 0.00 1.00 0.53 0.25 -0.05 -0.08 -0.09 0.00 
30.91 14.38 -5.11 0.86 -4.47 -1.11 26.74 9.80 3.64 -1.20 -1.83 -2.27 -1.75 
MGH 
1.10 0.87 -0.37 -0.03 0.01 0.00 1.13 0.57 0.45 -0.12 -0.36 0.04 0.00 
26.74 14.88 -8.18 -0.57 0.19 -0.57 23.22 8.16 5.17 -2.15 -6.66 0.80 -0.68 
MML 
0.92 0.73 0.10 0.06 -0.19 0.00 0.88 0.80 0.12 0.00 0.17 -0.07 0.00 
25.03 13.95 2.48 1.25 -3.99 0.11 22.87 14.37 1.74 0.01 3.99 -1.87 -0.62 
MMM 
0.94 0.62 0.08 0.02 -0.05 0.00 0.90 0.64 0.09 -0.02 0.09 0.01 0.00 
31.59 14.70 2.32 0.62 -1.27 0.91 27.93 13.87 1.49 -0.43 2.57 0.16 0.60 
MMH 
1.08 0.70 0.03 0.01 -0.13 0.00 1.03 0.68 0.08 -0.03 0.04 -0.06 0.00 
28.91 13.16 0.71 0.21 -2.63 0.61 25.08 11.40 1.02 -0.71 0.83 -1.39 0.35 
MVL 
1.21 1.22 0.60 -0.01 -0.48 0.00 1.11 1.31 0.24 0.05 0.35 -0.42 0.00 
27.26 19.28 12.25 -0.22 -8.47 1.26 20.18 16.49 2.41 0.85 5.59 -7.39 0.82 
MVM 
1.03 0.71 0.28 0.12 -0.07 0.00 0.97 0.73 0.08 0.11 0.20 -0.05 0.00 
30.91 15.11 7.79 2.77 -1.66 -0.09 24.96 13.09 1.20 2.44 4.67 -1.32 -0.07 
MVH 
1.06 0.60 0.23 -0.03 -0.07 0.00 1.01 0.64 0.06 -0.06 0.24 -0.04 0.00 
29.08 11.58 5.78 -0.68 -1.50 1.35 25.56 11.21 0.78 -1.43 5.42 -0.90 1.14 
BGL 
0.91 -0.15 0.01 -0.24 -0.21 0.00 0.87 -0.02 -0.25 -0.24 0.04 -0.14 0.00 
26.97 -3.10 0.22 -5.46 -4.92 0.32 24.51 -0.44 -3.97 -5.79 1.00 -3.83 0.07 
BGM 0.90 -0.24 0.06 -0.39 -0.07 0.00 0.90 -0.19 -0.15 -0.37 0.18 -0.02 0.00 
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29.56 -5.63 1.83 -9.57 -1.90 0.46 28.43 -4.06 -2.73 -10.10 5.00 -0.47 -0.13 
BGH 
1.01 0.05 -0.17 -0.33 0.09 0.00 1.01 -0.02 0.02 -0.33 -0.20 0.10 0.00 
26.72 1.00 -4.13 -6.46 1.75 0.27 25.01 -0.26 0.26 -7.02 -4.36 2.42 0.38 
BML 
1.08 0.04 -0.05 0.12 -0.22 0.00 1.09 0.05 -0.02 0.07 0.05 -0.17 0.00 
30.40 0.78 -1.28 2.59 -4.85 0.25 28.72 1.00 -0.27 1.71 1.14 -4.39 -0.20 
BMM 
0.97 0.02 0.03 -0.01 0.16 0.00 0.96 0.05 -0.04 -0.01 0.05 0.16 0.00 
34.44 0.59 1.05 -0.21 4.48 -1.70 32.03 1.07 -0.68 -0.19 1.36 5.15 -1.58 
BMH 
1.12 0.09 -0.05 0.06 0.02 0.00 1.09 0.09 -0.12 0.05 -0.10 0.05 0.00 
27.01 1.53 -1.08 1.06 0.47 -0.25 24.74 1.39 -1.52 1.05 -1.91 1.17 -0.06 
BVL 
1.00 0.12 0.10 0.53 -0.18 0.00 0.96 0.27 -0.13 0.49 0.09 -0.16 0.00 
28.85 2.35 2.75 11.55 -3.99 0.52 25.81 5.07 -1.88 11.41 2.05 -4.12 0.59 
BVM 
1.02 0.09 0.09 0.25 -0.11 0.00 0.99 0.17 -0.09 0.24 0.13 -0.08 0.00 
31.78 2.02 2.55 5.94 -2.78 1.22 29.64 3.49 -1.48 6.32 3.42 -2.34 1.03 
BVH 
0.93 -0.22 -0.08 0.32 0.04 0.00 0.94 -0.25 -0.11 0.30 -0.01 0.02 0.00 
25.35 -4.26 -1.96 6.62 0.80 1.62 24.25 -4.46 -1.63 6.65 -0.19 0.49 1.78 
GRS 
1.71           1.66             
p 
0.02           0.02             
Mean R2 
0.75           0.75             
The Table reports the results of the first-stage regression tests of the returns of the 27 
sequentially sorted size, book-to-market (BTM) and momentum portfolios on the 
Fama-French and Carhart factors, together with the result of the GRS F-test and the p-
value for the rejection of the null hypothesis that all the intercept (_cons) terms are 
jointly zero.  For the portfolios, the first letter denotes size (Small, S; Medium, M; 
Large, L), the second the BTM category (Low or “Glamour”, G; Medium, M; High, 
or “value”, V), and the third momentum (Low, L; Medium, M; High, H) category.  
The factors are rmrf, the market risk premium, hmls and hmlb, the decompositions of 
the hml factor as in Zhang (2008), MMB_CPZ, the mid-cap minus large cap factor, 
SMM_CPZ, the small cap minus mid-cap factor, BHML_CPZ and SHML_CPZ the 
decompositions of the hml_CPZ portfolio, all as described in Cremers et al. (2010). 
For each of the portfolios the table reports two rows; with the coefficient in the top 
row and the corresponding t-statistic in the bottom row. 
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Table 8: GRS Test Results for the 25 Standard Deviation Portfolios:  
Panel A. Basic Models 
Basic FF Basic Carhart 
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SD1 
0.71 0.01 0.02 0.00 0.71 0.01 0.03 0.01 0.00 
18.46 0.12 0.45 1.59 18.27 0.14 0.46 0.14 1.49 
SD2 
0.76 0.01 -0.06 0.00 0.77 0.02 -0.04 0.04 0.00 
23.21 0.21 -1.33 2.92 23.10 0.34 -0.67 0.94 2.55 
SD3 
0.84 -0.16 0.09 0.00 0.84 -0.16 0.11 0.04 0.00 
25.58 -3.44 1.94 1.18 25.43 -3.28 2.11 0.88 0.89 
SD4 
0.92 -0.14 0.10 0.00 0.93 -0.13 0.14 0.06 0.00 
26.67 -2.87 2.10 -0.84 26.62 -2.65 2.50 1.37 -1.19 
SD5 
0.86 -0.08 0.12 0.00 0.86 -0.08 0.13 0.02 0.00 
24.82 -1.57 2.58 1.68 24.59 -1.50 2.42 0.38 1.51 
SD6 
0.90 0.01 0.08 0.00 0.89 -0.01 0.02 -0.10 0.00 
23.98 0.12 1.57 0.05 23.55 -0.16 0.38 -1.94 0.58 
SD7 
0.85 0.12 0.03 0.00 0.85 0.12 0.03 0.00 0.00 
26.57 2.65 0.59 1.16 26.28 2.64 0.56 0.12 1.08 
SD8 
1.08 0.14 -0.19 0.00 1.06 0.11 -0.31 -0.19 0.00 
28.68 2.57 -3.63 -0.85 28.39 2.05 -5.15 -3.88 0.23 
SD9 
1.02 0.10 0.09 0.00 1.02 0.10 0.09 0.00 0.00 
27.10 1.81 1.68 -0.69 26.79 1.80 1.48 0.06 -0.68 
SD10 
0.99 0.32 0.08 0.00 1.01 0.34 0.18 0.16 0.00 
25.39 5.59 1.55 2.58 25.88 6.04 2.93 3.11 1.65 
SD11 
1.00 0.08 0.12 0.00 1.01 0.09 0.17 0.08 0.00 
26.29 1.41 2.34 0.87 26.29 1.62 2.80 1.54 0.41 
SD12 
0.99 0.30 0.05 0.00 0.98 0.29 0.00 -0.08 0.00 
23.40 4.93 0.77 -0.49 22.99 4.69 -0.05 -1.42 -0.08 
SD13 
1.06 0.32 -0.13 0.00 1.06 0.32 -0.14 -0.01 0.00 
27.95 5.83 -2.56 0.83 27.61 5.74 -2.28 -0.14 0.84 
SD14 
1.12 0.12 0.00 0.00 1.13 0.15 0.09 0.15 0.00 
25.19 1.92 -0.02 0.42 25.49 2.27 1.28 2.56 -0.31 
SD15 
1.11 0.41 0.01 0.00 1.11 0.40 -0.04 -0.08 0.00 
27.32 6.97 0.22 -0.52 26.87 6.70 -0.58 -1.52 -0.08 
SD16 
1.06 0.47 0.26 0.00 1.07 0.47 0.26 0.01 0.00 
27.29 8.29 4.75 -1.04 27.00 8.23 4.20 0.20 -1.06 
SD17 
1.16 0.49 0.02 0.00 1.15 0.48 -0.04 -0.10 0.00 
24.38 7.17 0.32 -1.27 23.95 6.90 -0.52 -1.57 -0.79 
SD18 
1.17 0.35 -0.05 0.00 1.18 0.38 0.03 0.13 0.00 
24.65 5.16 -0.71 -0.25 24.82 5.43 0.45 2.11 -0.83 
SD19 1.14 0.61 -0.08 0.00 1.12 0.58 -0.20 -0.20 0.00 
 50 
22.06 8.13 -1.09 0.13 21.65 7.72 -2.48 -3.03 0.97 
SD20 
1.23 0.76 -0.12 0.00 1.23 0.76 -0.10 0.05 0.00 
24.00 10.22 -1.76 1.50 23.83 10.21 -1.18 0.67 1.25 
SD21 
1.13 0.61 -0.23 0.00 1.13 0.61 -0.21 0.03 0.00 
21.69 8.06 -3.15 0.94 21.51 8.04 -2.47 0.49 0.77 
SD22 
1.15 0.57 -0.06 0.00 1.15 0.57 -0.06 0.01 0.00 
18.94 6.47 -0.75 -0.46 18.74 6.41 -0.59 0.11 -0.48 
SD23 
1.27 0.95 -0.27 0.00 1.24 0.90 -0.43 -0.27 0.00 
17.50 8.98 -2.66 -0.30 17.08 8.58 -3.76 -2.86 0.50 
SD24 
1.13 0.97 -0.30 0.00 1.13 0.98 -0.27 0.04 0.00 
18.07 10.70 -3.49 0.83 17.94 10.66 -2.75 0.52 0.65 
SD25 
 
1.22 1.50 -0.70 0.00 1.22 1.51 -0.68 0.03 0.00 
13.32 11.33 -5.56 -0.79 13.20 11.24 -4.67 0.24 -0.82 
GRS 1.47       1.13         
p 0.07       0.31         
Mean R2 0.62 
   
0.62 
    The Table reports the results of the first-stage regression tests of the returns of the 25 
portfolios ranked on their prior 12-month standard deviation of returns. SD1 is the 
portfolio with the lowest prior standard deviation, SD25 the portfolio with the highest.   
The portfolios are regressed on the Fama-French and Carhart factors, together with 
the result of the GRS F-test and the p-value for the rejection of the null hypothesis 
that all the intercept (_cons) terms are jointly zero.  The factors are rmrf, the market 
risk premium, smb, hml and umd are as defined in the text and on Ken French‟s 
website, with breakpoints formed using the largest 350 UK firms.  For each of the 
portfolios the table reports two rows; with the coefficient in the top row and the 
corresponding t-statistic in the bottom row. 
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Table 8: GRS Test Results for the 25 Standard Deviation Portfolios: 
Panel B. Value-Weighted Factor Components Models 
CPZ-FF CPZ-Carhart 
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SD1 
0.72 0.01 0.00 0.00 0.72 0.01 0.00 0.00 0.00 
18.34 0.12 -0.06 1.62 18.22 0.12 -0.08 -0.06 1.60 
SD2 
0.77 0.03 -0.04 0.00 0.77 0.03 -0.02 0.05 0.00 
23.11 0.74 -1.07 2.85 23.16 0.87 -0.48 1.36 2.51 
SD3 
0.83 -0.14 0.02 0.00 0.83 -0.14 0.02 0.00 0.00 
24.99 -3.81 0.45 1.47 24.84 -3.78 0.45 0.08 1.42 
SD4 
0.91 -0.14 0.04 0.00 0.91 -0.14 0.05 0.02 0.00 
26.12 -3.63 0.88 -0.56 26.02 -3.56 1.01 0.53 -0.66 
SD5 
0.85 -0.07 0.03 0.00 0.85 -0.08 0.01 -0.03 0.00 
24.29 -1.89 0.67 1.91 24.08 -1.96 0.31 -0.82 2.04 
SD6 
0.90 0.01 0.13 0.00 0.89 0.00 0.10 -0.06 0.00 
23.73 0.16 2.70 -0.06 23.52 0.01 1.91 -1.58 0.27 
SD7 
0.86 0.07 -0.01 0.00 0.86 0.07 -0.01 -0.01 0.00 
26.44 1.92 -0.15 1.15 26.25 1.87 -0.26 -0.34 1.20 
SD8 
1.10 0.08 -0.15 0.00 1.09 0.07 -0.20 -0.10 0.00 
28.40 1.77 -3.09 -0.93 28.24 1.52 -3.86 -2.56 -0.39 
SD9 
1.03 0.04 0.06 0.00 1.02 0.03 0.05 -0.02 0.00 
26.78 0.84 1.29 -0.67 26.58 0.79 1.04 -0.40 -0.57 
SD10 
1.01 0.19 -0.03 0.00 1.02 0.19 0.00 0.06 0.00 
25.22 4.18 -0.66 2.57 25.26 4.30 -0.09 1.38 2.23 
SD11 
0.99 0.03 0.11 0.00 1.00 0.04 0.15 0.08 0.00 
25.97 0.69 2.36 0.85 26.12 0.88 2.91 1.89 0.44 
SD12 
1.01 0.23 0.05 0.00 1.00 0.22 0.01 -0.08 0.00 
23.58 4.78 0.91 -0.70 23.37 4.59 0.16 -1.82 -0.31 
SD13 
1.08 0.24 -0.07 0.00 1.08 0.24 -0.06 0.02 0.00 
27.80 5.47 -1.41 0.49 27.70 5.49 -1.09 0.55 0.37 
SD14 
1.12 0.06 0.06 0.00 1.13 0.08 0.12 0.13 0.00 
24.96 1.29 1.08 0.28 25.32 1.56 2.03 2.70 -0.29 
SD15 
1.14 0.31 -0.04 0.00 1.14 0.31 -0.07 -0.06 0.00 
27.69 6.79 -0.70 -0.73 27.46 6.63 -1.18 -1.40 -0.42 
SD16 
1.09 0.35 0.14 0.00 1.09 0.35 0.13 -0.02 0.00 
27.34 7.80 2.87 -1.21 27.13 7.70 2.45 -0.53 -1.07 
SD17 
1.18 0.35 0.04 0.00 1.18 0.34 0.02 -0.06 0.00 
24.45 6.43 0.72 -1.55 24.24 6.29 0.24 -1.11 -1.29 
SD18 
1.19 0.22 0.01 0.00 1.19 0.23 0.05 0.09 0.00 
24.44 4.13 0.15 -0.48 24.57 4.29 0.80 1.76 -0.83 
SD19 1.18 0.47 -0.04 0.00 1.17 0.45 -0.10 -0.12 0.00 
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22.46 7.94 -0.67 -0.24 22.26 7.73 -1.45 -2.17 0.21 
SD20 
1.28 0.56 -0.10 0.00 1.28 0.56 -0.07 0.08 0.00 
24.15 9.39 -1.55 1.06 24.19 9.48 -0.93 1.34 0.76 
SD21 
1.17 0.48 -0.11 0.00 1.18 0.49 -0.06 0.10 0.00 
21.89 8.01 -1.64 0.46 22.03 8.17 -0.85 1.78 0.08 
SD22 
1.18 0.43 0.09 0.00 1.19 0.44 0.15 0.12 0.00 
19.17 6.26 1.20 -0.90 19.32 6.43 1.80 1.82 -1.26 
SD23 
1.34 0.75 -0.16 0.00 1.32 0.73 -0.23 -0.15 0.00 
18.03 9.05 -1.71 -0.76 17.83 8.85 -2.32 -1.93 -0.35 
SD24 
1.19 0.77 -0.10 0.00 1.20 0.78 -0.03 0.14 0.00 
18.49 10.66 -1.27 0.16 18.68 10.86 -0.40 2.07 -0.27 
SD25 
 
1.32 1.12 -0.40 -0.01 1.33 1.14 -0.32 0.17 -0.01 
13.45 10.22 -3.22 -1.34 13.57 10.35 -2.37 1.62 -1.65 
GRS 1.43       1.18         
p 0.09       0.26         
Mean R2 0.61 
   
0.61 
    The Table reports the results of the first-stage regression tests of the returns of the 25 
portfolios ranked on their prior 12-month standard deviation of returns. SD1 is the 
portfolio with the lowest prior standard deviation, SD25 the portfolio with the highest.   
The portfolios are regressed on the Fama-French and Carhart factors, together with 
the result of the GRS F-test and the p-value for the rejection of the null hypothesis 
that all the intercept (_cons) terms are jointly zero.  The factors are rmrf, the market 
risk premium, smb_CPZ, hml_CPZ and umd_CPZ, formed using the market 
capitalisations of the intersecting size and book-to-market, and size and momentum 
portfolios as described in Cremers et al. (2010).  For each of the portfolios the table 
reports two rows; with the coefficient in the top row and the corresponding t-statistic 
in the bottom row. 
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Table 8: GRS Test Results for the 25 Standard Deviation Portfolios:  
Panel C, Decomposed Factor Models  
Zhang Decomposition CPZ-Decomposition 
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SD1 
0.71 0.00 -0.01 0.01 0.00 0.00 0.72 0.03 -0.01 -0.02 0.07 0.02 0.00 
17.94 0.09 -0.18 0.26 -0.08 1.57 16.99 0.52 -0.10 -0.48 1.56 0.45 1.38 
SD2 
0.77 0.02 -0.01 0.00 0.05 0.00 0.74 0.08 -0.06 0.00 -0.06 0.05 0.00 
22.72 0.41 -0.34 -0.10 1.08 2.49 20.78 1.46 -0.89 -0.09 -1.60 1.27 2.76 
SD3 
0.85 -0.17 0.10 -0.07 0.02 0.00 0.85 -0.10 -0.13 -0.07 0.20 0.04 0.00 
25.62 -3.60 2.82 -1.65 0.50 1.10 24.43 -2.00 -2.04 -1.88 5.00 1.15 0.90 
SD4 
0.93 -0.15 0.05 0.01 0.04 0.00 0.94 -0.15 -0.07 0.00 0.13 0.04 0.00 
26.14 -2.92 1.17 0.31 0.77 -0.92 25.20 -2.82 -0.99 0.03 3.14 1.02 -1.09 
SD5 
0.88 -0.09 0.14 -0.08 0.01 0.00 0.86 -0.01 -0.11 -0.07 0.19 0.01 0.00 
24.96 -1.82 3.51 -1.69 0.16 1.67 23.19 -0.10 -1.72 -1.69 4.44 0.38 1.60 
SD6 
0.88 0.00 -0.02 0.11 -0.08 0.00 0.86 0.05 -0.09 0.12 -0.08 -0.07 0.00 
23.15 -0.09 -0.48 2.16 -1.55 0.39 21.22 0.89 -1.19 2.68 -1.76 -1.72 0.57 
SD7 
0.86 0.12 0.04 -0.05 -0.01 0.00 0.84 0.15 -0.03 -0.06 0.04 0.01 0.00 
26.15 2.55 1.08 -1.24 -0.13 1.21 23.94 2.89 -0.52 -1.41 1.00 0.18 1.22 
SD8 
1.05 0.13 -0.19 -0.07 -0.19 0.00 1.06 0.05 0.00 -0.10 -0.16 -0.12 0.00 
27.66 2.50 -4.47 -1.38 -3.91 0.20 25.58 0.82 -0.02 -2.16 -3.48 -2.80 -0.07 
SD9 
1.02 0.09 0.03 0.03 -0.01 0.00 1.00 0.12 -0.08 0.02 0.04 0.01 0.00 
26.36 1.67 0.62 0.62 -0.16 -0.59 24.18 2.09 -1.02 0.52 0.82 0.13 -0.56 
SD10 
1.03 0.32 0.16 -0.08 0.14 0.00 0.97 0.40 -0.06 -0.08 0.15 0.13 0.00 
26.19 5.78 3.72 -1.46 2.84 1.85 23.26 6.66 -0.78 -1.67 3.09 3.04 2.09 
SD11 
1.01 0.08 0.09 0.09 0.09 0.00 0.99 0.16 -0.07 0.07 0.13 0.11 0.00 
26.10 1.45 2.07 1.71 1.75 0.34 24.17 2.74 -0.99 1.54 2.74 2.72 0.28 
SD12 
0.98 0.29 0.02 0.04 -0.05 0.00 1.00 0.21 0.23 0.05 -0.03 -0.08 0.00 
22.69 4.79 0.35 0.74 -0.96 -0.28 21.58 3.12 2.75 0.87 -0.58 -1.79 -0.30 
SD13 
1.04 0.33 -0.11 0.06 0.01 0.00 1.02 0.33 0.05 0.01 -0.14 0.03 0.00 
26.91 6.07 -2.67 1.13 0.19 0.66 24.70 5.49 0.70 0.20 -2.99 0.61 0.78 
SD14 
1.11 0.15 -0.10 0.21 0.14 0.00 1.09 0.17 -0.06 0.15 -0.06 0.14 0.00 
25.01 2.30 -1.98 3.62 2.39 -0.28 22.84 2.47 -0.64 2.79 -1.04 2.81 -0.10 
SD15 
1.12 0.40 0.08 -0.10 -0.06 0.00 1.12 0.41 0.20 -0.11 0.14 -0.01 0.00 
27.02 6.82 1.81 -1.81 -1.07 -0.23 25.51 6.43 2.49 -2.11 2.73 -0.15 -0.75 
SD16 
1.08 0.45 0.18 0.04 0.01 0.00 1.05 0.57 0.11 0.01 0.17 0.04 0.00 
27.13 7.96 4.08 0.77 0.29 -1.05 25.20 9.43 1.43 0.15 3.71 0.92 -1.26 
SD17 
1.13 0.48 -0.11 0.10 -0.11 0.00 1.15 0.43 0.23 0.02 0.03 -0.03 0.00 
23.40 7.07 -2.07 1.56 -1.70 -0.79 22.01 5.73 2.40 0.28 0.55 -0.51 -1.33 
SD18 
1.17 0.38 -0.03 0.12 0.14 0.00 1.14 0.33 0.06 0.09 -0.13 0.08 0.00 
24.36 5.52 -0.58 1.88 2.34 -0.95 21.97 4.35 0.66 1.59 -2.27 1.60 -0.46 
SD19 
1.11 0.60 -0.11 -0.01 -0.18 0.00 1.13 0.58 0.27 -0.08 0.02 -0.08 0.00 
21.09 7.99 -1.93 -0.14 -2.73 0.82 19.93 7.06 2.65 -1.31 0.33 -1.32 0.17 
SD20 1.23 0.78 -0.05 0.02 0.07 0.00 1.23 0.63 0.39 0.02 -0.16 0.07 0.00 
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23.36 10.40 -0.83 0.26 0.98 1.11 21.61 7.73 3.87 0.30 -2.48 1.28 1.06 
SD21 
1.11 0.64 -0.20 0.11 0.05 0.00 1.13 0.50 0.38 0.06 -0.22 0.08 0.00 
20.87 8.45 -3.40 1.58 0.75 0.61 19.84 6.11 3.76 0.95 -3.41 1.36 0.45 
SD22 
1.13 0.59 -0.13 0.24 0.05 0.00 1.15 0.48 0.36 0.19 -0.15 0.09 0.00 
18.28 6.72 -1.97 2.87 0.58 -0.73 17.45 5.07 3.00 2.45 -2.00 1.33 -0.93 
SD23 
1.24 0.95 -0.12 -0.08 -0.19 0.00 1.26 0.78 0.55 -0.11 -0.21 -0.15 0.00 
16.55 8.90 -1.47 -0.81 -1.95 0.12 15.77 6.79 3.87 -1.20 -2.30 -1.89 -0.11 
SD24 
1.10 1.01 -0.23 0.17 0.09 0.00 1.10 0.84 0.54 0.14 -0.41 0.09 0.00 
17.29 11.15 -3.26 1.97 1.13 0.34 16.56 8.77 4.54 1.82 -5.45 1.33 0.44 
SD25 
1.17 1.57 -0.46 0.13 0.11 -0.01 1.17 1.16 0.77 0.03 -0.79 0.06 0.00 
12.44 11.79 -4.41 1.04 0.91 -1.17 11.69 8.05 4.33 0.28 -7.01 0.61 -0.88 
GRS 1.11           1.27             
p 0.32           0.18             
Mean R2 0.63           0.63             
The Table reports the results of the first-stage regression tests of the returns of the 25 
portfolios ranked on their prior 12-month standard deviation of returns. SD1 is the 
portfolio with the lowest prior standard deviation, SD25 the portfolio with the highest.   
The portfolios are regressed on the Fama-French and Carhart factors, together with 
the result of the GRS F-test and the p-value for the rejection of the null hypothesis 
that all the intercept (_cons) terms are jointly zero.  The factors are rmrf , the market 
risk premium, hmls and hmlb, the decompositions of the hml factor as in Zhang 
(2008), MMB_CPZ, the mid-cap minus large cap factor, SMM_CPZ, the small cap 
minus mid-cap factor, BHML_CPZ and SHML_CPZ the decompositions of the 
hml_CPZ portfolio, all as described in Cremers et al. (2010). For each of the 
portfolios the table reports two rows; with the coefficient in the top row and the 
corresponding t-statistic in the bottom row. 
SGM 
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Table 9: Fama-Macbeth regression tests with the 25 (5x5) size and book-to-market portfolios: 
Panel A: Basic FF and Carhart models, and Value-Weighted Factor Components Models. 
 Basic FF Basic Carhart 
Basic FF & Carhart Models Single Rolling Single Rolling 
Variable Mean sh-t sh-p Mean sh-t sh-p Mean sh-t sh-p Mean sh-t sh-p 
cons 0.43 1.11 0.26 0.62 1.90 0.00 0.27 0.65 0.51 0.27 0.74 0.45 
rmrf 0.10 0.22 0.82 -0.21 -0.60 0.55 0.28 0.61 0.54 0.20 0.580 0.564 
smb 0.07 0.45 0.65 0.03 0.17 0.86 0.08 0.49 0.62 0.01 0.100 0.921 
hml 0.42 2.10 0.03 0.36 1.78 0.07 0.50 2.53 0.01 0.47 2.450 0.015 
umd             0.56 0.86 0.39 0.58 1.670 0.096 
Cross-sect ional R
2
 0.60     0.59     0.61     0.60     
chi-squared 19.22     26.72     15.21     24.50     
p-value 0.63     0.22     0.81     0.27     
 CPZ-FF CPZ-Carhart 
Value -Weighted Factor Components Models 
 
Single 
 
Rolling Single Rolling 
cons 0.42 1.07 0.28 0.71 2.21 0.02 0.43 1.09 0.27 0.47 1.400 0.163 
rmrf 0.10 0.22 0.82 -0.30 -0.86 0.39 0.08 0.19 0.85 -0.01 -0.050 0.962 
smb_CPZ 0.16 0.72 0.47 0.11 0.48 0.63 0.16 0.71 0.47 0.09 0.390 0.696 
hml_CPZ 0.57 2.30 0.02 0.46 2.09 0.03 0.55 2.54 0.01 0.59 2.860 0.005 
umd_CPZ             -0.39 -0.56 0.57 0.57 1.420 0.156 
Cross-sect ional R
2
 0.60     0.58     0.61     0.59     
chi-squared 22.28     27.46     22.10     27.05     
p-value 0.44     0.19     0.39     0.16     
The Table reports the results of Fama-Macbeth regressions, with sh-t and sh-p denoting the t-test and p-values from the Shanken (1992) errors-
in-variables adjusted tests.  The factors are rmrf-the market risk premium, smb, hml and umd are as defined in the text and on Ken French‟s 
website, with breakpoints formed using the largest 350 UK firms, smb_CPZ, hml_CPZ and umd_CPZ , formed using the market capitalisations 
of the intersecting size and book-to-market (BTM), and size and momentum portfolios as described in Cremers et al. (2010).   
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Panel B: Decomposed Factor Models 
 Zhang decomposition CPZ-decomposition 
Decomposed Models Single Rolling Single Rolling 
Variable Mean sh-t sh-p Mean sh-t sh-p Mean sh-t sh-p Mean sh-t sh-p 
cons 0.24 0.53 0.59 0.23 0.64 0.52 -0.40 -0.56 0.57 0.24 0.63 0.53 
rmrf 0.30 0.65 0.51 0.28 0.76 0.44 0.97 1.33 0.18 0.27 0.79 0.43 
smb 0.09 0.54 0.58 0.02 0.14 0.88            
hmls 0.89 2.58 0.01 0.45 1.53 0.12             
hmlb 0.55 2.42 0.01 0.46 2.20 0.02             
umd 0.79 1.20 0.22 0.55 1.70 0.08             
MMB_CPZ             0.08 0.45 0.65 0.12 0.63 0.53 
SMM_CPZ             0.15 0.92 0.35 0.03 0.20 0.84 
BHML_CPZ             0.50 2.14 0.03 0.42 1.89 0.05 
SHML_CPZ             0.59 2.06 0.04 0.51 1.79 0.07 
umd_CPZ             -0.34 -0.44 0.66 0.79 1.97 0.04 
Cross-sect ional R
2
 0.62     0.61     0.63     0.62     
chi-squared 12.66     22.77     18.65     20.45     
p-value 0.89     0.30     0.47     0.36     
The Table reports the results of Fama-Macbeth regressions, with sh-t and sh-p denoting the t-test and p-values from the Shanken (1992) errors-
in-variables adjusted tests.  The factors are rmrf, the market risk premium, hmls and hmlb, the decompositions of the hml factor as in Zhang 
(2008), MMB_CPZ, the mid-cap minus large cap factor, SMM_CPZ, the small cap minus mid-cap factor, BHML_CPZ and SHML_CPZ the 
decompositions of the hml_CPZ portfolio, are as described in Cremers et al. (2010).
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Table 10: Fama-Macbeth regression tests with the 27 sequential size, book-to-market and momentum portfolios: 
Panel A: Basic FF and Carhart models and Value -Weighted Factor Components Models. 
 Basic FF Basic Cremers 
Basic FF & Carhart Models Single Rolling Single Rolling 
Variable Mean sh-t sh-p Mean sh-t sh-p Mean sh-t sh-p Mean sh-t sh-p 
cons 0.87 2.29 0.02 0.71 2.09 0.03 0.40 0.99 0.32 0.53 1.53 0.12 
rmrf -0.36 -0.85 0.39 -0.34 -1.03 0.30 0.13 0.31 0.75 -0.09 -0.28 0.77 
smb 0.05 0.28 0.78 0.08 0.43 0.67 0.11 0.62 0.53 0.08 0.42 0.67 
hml 0.48 2.33 0.02 0.35 1.62 0.10 0.62 3.13 0.00 0.39 1.83 0.06 
umd             0.56 1.50 0.13 0.24 0.78 0.43 
Cross-sect ional R
2
 0.57     0.57     0.59     0.57    
chi-squared 43.35     49.41     37.41     47.01     
p-value 0.00     0.00     0.02     0.00     
 CPZ-FF CPZ-Carhart 
Value -Weighted Factor Components Models 
Single Rolling Single Rolling 
cons 0.96 2.49 0.01 0.72 2.11 0.03 0.73 1.77 0.07 0.59 1.67 0.09 
rmrf -0.45 -1.04 0.29 -0.32 -0.97 0.33 -0.20 -0.45 0.65 -0.15 -0.44 0.65 
smb_CPZ 0.17 0.74 0.45 0.17 0.69 0.49 0.23 0.99 0.32 0.17 0.68 0.49 
hml_CPZ 0.58 2.29 0.02 0.33 1.33 0.18 0.81 3.44 0.00 0.38 1.65 0.10 
umd_CPZ            0.39 0.89 0.37 0.23 0.63 0.53 
Cross-sect ional R
2
 0.57     0.56     0.58     0.57     
chi-squared 44.09     44.35     45.10     40.90     
p-value 0.00     0.00     0.00     0.01     
The Table reports the results of Fama-Macbeth regressions, with sh-t and sh-p denoting the t-test and p-values from the Shanken (1992) errors-
in-variables adjusted tests.  The factors are rmrf-the market risk premium, smb, hml and umd are as defined in the text and on Ken French‟s 
website, with breakpoints formed using the largest 350 UK firms, smb_CPZ, hml_CPZ and umd_CPZ , formed using the market capitalisations 
of the intersecting size and book-to-market, and size and momentum portfolios as described in Cremers et al. (2010). 
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Panel B: Decomposed Factor Models 
 Zhang decomposition CPZ-decomposition 
Decomposed Models Single Rolling Single Rolling 
Variable Mean sh-t sh-p Mean sh-t sh-p Mean sh-t sh-p Mean sh-t sh-p 
cons 0.54 1.20 0.23 0.53 1.50 0.13 -0.57 -0.94 0.34 0.20 0.49 0.62 
rmrf 0.00 0.01 0.98 -0.10 -0.30 0.76 1.13 1.92 0.05 0.28 0.72 0.47 
smb 0.10 0.59 0.55 0.07 0.36 0.71           
hmls 0.89 2.53 0.01 0.46 1.66 0.09             
hmlb 0.72 2.87 0.00 0.31 1.27 0.20             
umd 0.65 1.63 0.10 0.17 0.59 0.55             
MMB_CPZ             -0.02 -0.12 0.90 0.00 0.03 0.97 
SMM_CPZ             0.25 1.37 0.17 0.25 1.40 0.16 
BHML_CPZ             0.58 2.27 0.02 0.13 0.55 0.58 
SHML_CPZ             1.09 3.56 0.00 0.77 2.70 0.00 
umd_CPZ             0.89 1.92 0.05 0.29 0.78 0.43 
Cross-sect ional R
2
 0.59     0.58     0.60     0.59     
chi-squared 36.42     39.61     30.41     32.03     
p-value 0.02     0.01     0.08     0.05     
The Table reports the results of Fama-Macbeth regressions, with sh-t and sh-p denoting the t-test and p-values from the Shanken (1992) errors-
in-variables adjusted tests.  The factors are rmrf, the market risk premium, hmls and hmlb, the decompositions of the hml factor as in Zhang 
(2008), MMB_CPZ, the mid-cap minus large cap factor, SMM_CPZ, the small cap minus mid-cap factor, BHML_CPZ and SHML_CPZ the 
decompositions of the hml_CPZ portfolio, all as described in Cremers et al. (2010).
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Table 11: Fama-Macbeth regression tests for the models with the 25 Standard Deviation portfolios: 
Panel A: Basic FF and Carhart models and Value -Weighted Factor Components Models. 
 Basic FF Basic Carhart 
Basic FF & Carhart Models Single Rolling Single Rolling 
Variable Mean sh-t sh-p Mean sh-t sh-p Mean sh-t sh-p Mean sh-t sh-p 
cons 0.93 1.80 0.07 1.06 2.54 0.01 0.83 1.51 0.13 1.02 2.44 0.01 
rmrf -0.36 -0.63 0.52 -0.67 -1.64 0.10 -0.25 -0.45 0.65 -0.64 -1.57 0.11 
smb 0.16 0.57 0.57 0.26 1.13 0.25 0.16 0.54 0.58 0.34 1.46 0.14 
hml 0.28 0.64 0.52 0.38 1.47 0.14 0.25 0.55 0.58 0.44 1.68 0.09 
umd            0.56 0.91 0.36 -0.35 -1.07 0.28 
Cross-sect ional R
2
 0.48     0.47     0.48     0.48     
chi-squared 27.26     25.27     20.48     23.57     
p-value 0.20     0.28     0.49     0.31     
 CPZ-FF CPZ-Carhart 
Value -Weighted Factor Components Models. Single Rolling Single Rolling 
cons 0.89 1.85 0.06 1.07 2.62 0.00 0.83 1.66 0.09 0.99 2.45 0.01 
rmrf -0.29 -0.54 0.59 -0.67 -1.66 0.09 -0.23 -0.42 0.67 -0.63 -1.58 0.11 
smb_CPZ 0.09 0.25 0.80 0.38 1.26 0.20 0.02 0.05 0.95 0.41 1.35 0.17 
hml_CPZ 0.06 0.11 0.91 0.30 1.05 0.29 0.06 0.10 0.92 0.44 1.49 0.13 
umd_CPZ 
           0.67 0.91 0.36 -0.41 -1.05 0.29 
Cross-sect ional R
2
 0.48     0.47     0.49     0.49     
chi-squared 27.88     21.91     22.91     23.10     
p-value 0.18     0.46     0.34     0.33     
The Table reports the results of Fama-Macbeth regressions, with sh-t and sh-p denoting the t-test and p-values from the Shanken (1992) errors-
in-variables adjusted tests.  The factors are rmrf-the market risk premium, smb, hml and umd are as defined in the text and on Ken French‟s 
website, with breakpoints formed using the largest 350 UK firms, smb_CPZ, hml_CPZ and umd_CPZ , formed using the market capitalisations 
of the intersecting size and book-to-market, and size and momentum portfolios as described in Cremers et al. (2010). 
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Panel B: Decomposed Factor Models 
 Zhang decomposition CPZ-decomposition 
Decomposed Factor Models Single Rolling Single Rolling 
Variable Mean sh-t sh-p Mean sh-t sh-p Mean sh-t sh-p Mean sh-t sh-p 
cons 0.63 1.12 0.26 0.87 1.91 0.05 0.81 1.45 0.14 0.81 1.74 0.08 
rmrf -0.02 -0.04 0.96 -0.47 -1.11 0.26 -0.28 -0.52 0.60 -0.42 -0.98 0.32 
smb 0.07 0.25 0.79 0.32 1.35 0.17           
hmls 0.32 0.52 0.60 0.37 0.87 0.38             
hmlb -0.62 -0.91 0.36 0.46 1.47 0.14             
umd 1.01 1.57 0.11 -0.17 -0.54 0.59             
MMB_CPZ             0.22 0.60 0.55 0.22 0.83 0.40 
SMM_CPZ             -0.01 -0.03 0.97 0.31 1.08 0.28 
BHML_CPZ             -0.46 -0.66 0.50 0.58 1.70 0.09 
SHML_CPZ             0.26 0.57 0.56 0.28 0.78 0.43 
umd_CPZ             1.37 1.81 0.07 -0.25 -0.61 0.54 
Cross-sect ional R
2
 0.49     0.49     0.49     0.50     
chi-squared 16.79     20.63     15.70     16.56     
p-value 0.66     0.41     0.67     0.61     
The Table reports the results of Fama-Macbeth regressions, with sh-t and sh-p denoting the t-test and p-values from the Shanken (1992) errors-
in-variables adjusted tests.  The factors are rmrf, the market risk premium, hmls and hmlb, the decompositions of the hml factor as in Zhang 
(2008), MMB_CPZ, the mid-cap minus large cap factor, SMM_CPZ, the small cap minus mid-cap factor, BHML_CPZ and SHML_CPZ the 
decompositions of the hml_CPZ portfolio, all as described in Cremers et al. (2010).
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Table 12: GRS Test results for models based on the largest 350 firms only 
Portfolios 25 Size and BTM 12 Size, B/M and Momentum 12 Standard Deviation 
Models GRS-F stat p Mean R
2
 GRS-F stat p Mean R
2
 GRS-F stat P Mean R
2
 
Basic Models          
Basic FF 0.69 0.86 0.73 1.39 0.16 0.79 1.47 0.13 0.70 
Basic Carhart 0.87 0.64 0.73 1.25 0.24 0.79 1.05 0.40 0.70 
Value-Weighted Factor Components model          
CPZ-FF 0.66 0.88 0.73 1.51 0.11 0.78 1.59 0.09 0.70 
CPZ-Carhart 0.77 0.77 0.74 1.31 0.20 0.78 1.27 0.23 0.70 
Decomposed Factor Models          
Zhang decomposition 0.75 0.80 0.75 0.95 0.49 0.81 1.04 0.41 0.70 
CPZ-decomposition 0.65 0.90 0.76 1.09 0.36 0.80 1.08 0.37 0.71 
The Table reports the results of the first-stage GRS  tests of the returns of the 5x5 size and book-to-market (BTM) portfolios, 2x2x3 sequentially 
sorted size, BTM and momentum portfolios and 12  portfolios ranked on their prior 12-month standard deviation of returns, all formed from the 
largest 350 firms only. The portfolios are regressed on the Fama-French and Carhart factors, formed on the basis of only the largest 350 firms.  
“GRS” shows the result of the GRS F-test and the p-value for the rejection of the null hypothesis that all the intercept (_cons) terms are jointly 
zero.  The mean adjusted R-squared for each model is also shown. 
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Table 13: Fama-Macbeth regression tests with the 25 (5x5) size and book-to-market portfolios formed from the largest 350 firms. 
Panel A: Basic FF and Carhart Models, and Value-Weighted Factor Components model 
 Basic FF Basic Carhart 
Basic Models Single Rolling Single Rolling 
Variable Mean sh-t sh-p Mean sh-t sh-p Mean sh-t sh-p Mean sh-t sh-p 
cons -0.23 -0.44 0.65 0.14 0.41 0.68 -0.24 -0.45 0.65 0.06 0.17 0.86 
rmrf 0.78 1.36 0.17 0.31 0.89 0.37 0.79 1.38 0.16 0.45 1.26 0.21 
smb 0.11 0.60 0.55 0.05 0.30 0.76 0.12 0.65 0.51 0.09 0.46 0.64 
hml 0.56 2.22 0.02 0.54 2.32 0.02 0.60 2.29 0.02 0.65 2.75 0.00 
umd       -0.15 -0.23 0.82 0.17 0.52 0.60 
Cross-sect ional R
2
 0.56   0.55   0.56   0.55   
chi-squared 
10.6   16.7   10.5   16.8   
p-value 0.97   0.77   0.97   0.72   
 CPZ-FF CPZ-Carhart 
Value-Weighted Factor Components model Single Rolling Single Rolling 
cons -0.18 -0.31 0.75 0.18 0.50 0.62 -0.25 -0.41 0.68 0.11 0.30 0.76 
rmrf 0.71 1.17 0.24 0.26 0.72 0.47 0.80 1.30 0.19 0.36 0.98 0.32 
smb_CPZ 0.13 0.77 0.44 0.02 0.15 0.88 0.11 0.67 0.50 0.02 0.15 0.87 
hml_CPZ 0.60 2.40 0.01 0.51 2.19 0.02 0.48 2.23 0.02 0.54 2.50 0.01 
umd_CPZ       -0.94 -1.23 0.22 0.24 0.61 0.54 
Cross-sect ional R
2
 0.55   0.54   0.56   0.55   
chi-squared 19.3   20.0   13.5   21.6   
p-value 0.62   0.58   0.88   0.41   
The Table reports the results of Fama-Macbeth regressions, with sh-t and sh-p denoting the t-test and p-values from the Shanken (1992) errors-
in-variables adjusted tests.  The factors are rmrf-the market risk premium, smb, hml and umd are as defined in the text and on Ken French‟s 
website, formed using only the largest 350 UK firms, smb_CPZ, hml_CPZ and umd_CPZ , formed using the market capitalisations of the 
intersecting size and book-to-market, and size and momentum portfolios as described in Cremers et al. (2010). 
 63 
Panel B: Decomposed Factor Models 
 Zhang Decomposition CPZ-decomposition 
Decomposed Factor Models Single Rolling Single Rolling 
Variable Mean sh-t sh-p Mean sh-t sh-p Mean sh-t sh-p Mean sh-t sh-p 
cons -0.25 -0.45 0.65 0.00 0.02 0.98 -0.22 -0.38 0.70 -0.23 -0.62 0.53 
rmrf 0.79 1.37 0.17 0.52 1.42 0.15 0.77 1.25 0.21 0.76 2.13 0.03 
smb 0.07 0.40 0.68 0.07 0.37 0.70       
hmls 0.44 1.57 0.11 0.37 1.33 0.18       
hmlb 0.48 2.12 0.03 0.46 2.18 0.03       
umd -0.46 -0.70 0.48 0.02 0.08 0.93       
smb_CPZ       0.11 0.67 0.50 0.03 0.16 0.87 
BHML_CPZ       0.44 1.83 0.06 0.46 2.07 0.03 
SHML_CPZ       0.53 1.99 0.04 0.43 1.50 0.13 
umd_CPZ       -0.14 -0.16 0.87 0.03 0.10 0.91 
Cross-sect ional R
2
 0.57   0.56   0.57   0.56   
chi-squared 11.81   19.15   10.93   15.96   
p-value 0.92   0.51   0.94   0.71   
The Table reports the results of Fama-Macbeth regressions, with sh-t and sh-p denoting the t-test and p-values from the Shanken (1992) errors-
in-variables adjusted tests.  The factors are rmrf, the market risk premium, hmls and hmlb, the decompositions of the hml factor as in Zhang 
(2008), MMB_CPZ, the mid-cap minus large cap factor, smb_CPZ, here the mid-cap minus the large-cap return (small firms being excluded 
from this largest firms portfolio), BHML_CPZ and SHML_CPZ the decompositions of the hml_CPZ portfolio, all as described in Cremers et al. 
(2010). 
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Table 14: Fama-Macbeth regression tests with the 12 size, book-to-market and momentum portfolios formed from the largest 350 firms  
Panel A: Basic FF and Carhart Models, and Value-Weighted Factor Components model 
 Basic FF Basic Carhart 
Basic FF & Carhart Models Single Rolling Single Rolling 
Variable Mean sh-t sh-p Mean sh-t sh-p Mean sh-t sh-p Mean sh-t sh-p 
cons -0.64 -0.80 0.42 0.28 0.49 0.62 -0.77 -0.90 0.36 -0.16 -0.24 0.80 
rmrf 1.18 1.45 0.14 0.11 0.19 0.84 1.35 1.65 0.10 0.71 1.10 0.27 
smb 0.01 0.08 0.93 -0.06 -0.30 0.76 0.15 0.78 0.43 -0.03 -0.17 0.86 
hml 0.39 1.32 0.18 0.28 1.04 0.30 0.74 2.69 0.00 0.38 1.40 0.16 
umd       1.02 2.06 0.04 0.56 1.14 0.25 
Cross-sect ional R
2
 0.61   0.61   0.62   0.63   
chi-squared 14.21   17.32   3.58   14.52   
p-value 0.11   0.04   0.89   0.06   
 CPZ-FF CPZ-Carhart 
Value-Weighted Factor Components model Single Running Single Running 
cons -0.35 -0.40 0.68 0.63 1.08 0.28 -0.18 -0.21 0.83 0.24 0.37 0.71 
rmrf 0.87 0.98 0.32 -0.26 -0.47 0.64 0.71 0.81 0.41 0.28 0.48 0.63 
smb_CPZ 0.06 0.33 0.73 -0.05 -0.26 0.79 0.14 0.76 0.44 -0.03 -0.14 0.89 
hml_CPZ 0.43 1.61 0.10 0.24 0.89 0.37 0.69 2.76 0.00 0.41 1.59 0.11 
umd_CPZ       0.56 1.04 0.30 1.05 1.71 0.08 
Cross-sect ional R
2
 0.60   0.61   0.62   0.63   
chi-squared 14.21   17.40   11.32   12.03   
p-value 0.11   0.04   0.18   0.15   
The Table reports the results of Fama-Macbeth regressions, with sh-t and sh-p denoting the t-test and p-values from the Shanken (1992) errors-
in-variables adjusted tests.  The factors are rmrf-the market risk premium, smb, hml and umd are as defined in the text and on Ken French‟s 
website, formed using only the largest 350 UK firms, smb_CPZ, hml_CPZ and umd_CPZ , formed using the market capitalisations of the 
intersecting size and book-to-market, and size and momentum portfolios as described in Cremers et al. (2010). 
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Panel B: Decomposed Factor Models 
 Zhang decomposition CPZ-decomposition 
Decomposed Factor Models Single Rolling Single Rolling 
Variable Mean sh-t sh-p Mean sh-t sh-p Mean sh-t sh-p Mean sh-t sh-p 
cons -1.02 -1.13 0.26 0.79 0.66 0.51 -1.62 -1.58 0.11 -0.04 -0.06 0.95 
rmrf 1.60 1.82 0.07 -0.38 -0.34 0.73 2.18 2.31 0.02 0.65 0.87 0.38 
smb 0.02 0.11 0.91 -0.06 -0.32 0.74       
hmls 0.64 2.19 0.03 0.69 2.29 0.02       
hmlb 0.53 2.00 0.04 0.38 1.33 0.18       
umd 0.76 1.67 0.09 0.62 1.21 0.22       
smb_CPZ       0.21 1.10 0.27 -0.02 -0.12 0.90 
BHML_CPZ       0.44 1.52 0.13 0.22 0.71 0.47 
SHML_CPZ       0.68 2.23 0.02 0.83 2.38 0.01 
umd_CPZ       1.37 2.13 0.03 1.51 2.49 0.01 
Cross-sect ional R
2
 0.64   0.63   0.64   0.64   
chi-squared 3.29   7.21   4.11   9.96   
p-value 0.85   0.40   0.76   0.19   
The Table reports the results of Fama-Macbeth regressions, with sh-t and sh-p denoting the t-test and p-values from the Shanken (1992) errors-
in-variables adjusted tests.  The factors are rmrf, the market risk premium, hmls and hmlb, the decompositions of the hml factor as in Zhang 
(2008), MMB_CPZ, the mid-cap minus large cap factor, smb_CPZ, here the mid-cap minus the large-cap return (small firms being excluded 
from this largest firms portfolio), BHML_CPZ and SHML_CPZ the decompositions of the hml_CPZ portfolio, all as described in Cremers et al. 
(2010). 
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Table 15: Fama-Macbeth regression tests with the 12 standard deviation portfolios formed from the largest 350 firms. 
Panel A: Basic FF and Carhart Models, and Value-Weighted Factor Components model 
 Basic FF Basic Carhart 
Basic FF & Carhart Models Single Rolling Single Rolling 
Variable Mean sh-t sh-p Mean sh-t sh-p Mean sh-t sh-p Mean sh-t sh-p 
cons 0.61 0.68 0.50 0.78 1.68 0.09 0.72 0.68 0.49 0.89 1.74 0.08 
rmrf 0.00 0.00 0.99 -0.28 -0.62 0.53 0.15 -0.18 0.86 -0.39 -0.77 0.44 
smb -0.55 -1.01 0.31 -0.34 -1.07 0.28 -0.11 -0.19 0.84 -0.17 -0.52 0.60 
hml -0.75 -1.27 0.20 0.11 0.26 0.79 -0.26 -0.41 0.68 0.15 0.34 0.73 
umd       1.51 2.17 0.03 -0.01 -0.04 0.97 
Cross-sect ional R
2
 0.50   0.49   0.50   0.49   
chi-squared 10.27   13.93   7.12   13.03   
p-value 0.59   0.30   0.78   0.29   
 CPZ-FF CPZ-Carhart 
Value-Weighted Factor Components model Single Running Single Running 
cons 0.76 0.83 0.40 0.79 1.61 0.10 1.05 0.80 0.42 0.81 1.57 0.11 
rmrf -0.17 -0.18 0.85 -0.32 -0.70 0.48 -0.52 -0.54 0.59 -0.34 -0.66 0.50 
smb_CPZ -0.12 -0.27 0.78 0.00 0.03 0.97 0.01 0.04 0.96 0.02 0.10 0.92 
hml_CPZ 0.22 0.34 0.73 0.40 1.08 0.28 0.80 1.17 0.24 0.36 0.95 0.34 
umd_CPZ       1.82 2.45 0.01 0.01 0.03 0.97 
Cross-sect ional R
2
 0.49   0.47   0.49   0.48   
chi-squared 11.54   13.70   2.91   10.49   
p-value 0.48   0.32   0.99   0.48   
The Table reports the results of Fama-Macbeth regressions, with sh-t and sh-p denoting the t-test and p-values from the Shanken (1992) errors-
in-variables adjusted tests.  The factors are rmrf-the market risk premium, smb, hml and umd are as defined in the text and on Ken French‟s 
website, formed using only the largest 350 UK firms, smb_CPZ, hml_CPZ and umd_CPZ , formed using the market capitalisations of the 
intersecting size and book-to-market, and size and momentum portfolios as described in Cremers et al. (2010). 
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Panel B: Decomposed Factor Models 
 Zhang decomposition CPZ-decomposition 
Decomposed Factor Models Single Rolling Single  Rolling   
Variable Mean sh-t sh-p Mean sh-t sh-p Mean sh-t sh-p Mean sh-t sh-p 
cons 0.92 0.90 0.37 0.58 1.09 0.27 1.21 0.87 0.38 0.52 0.99 0.32 
rmrf -0.36 -0.40 0.68 -0.03 -0.07 0.94 -0.68 -0.66 0.50 -0.01 -0.02 0.98 
smb -0.23 -0.38 0.70 -0.17 -0.51 0.60       
hmls -0.26 -0.43 0.66 0.50 1.03 0.30       
hmlb 0.78 1.16 0.24 -0.11 -0.27 0.78       
umd 1.31 1.92 0.05 -0.01 -0.04 0.97       
smb_CPZ       -0.02 -0.06 0.95 0.02 0.09 0.93 
BHML_CPZ       0.98 1.35 0.17 -0.07 -0.16 0.87 
SHML_CPZ       -0.19 -0.33 0.74 0.48 0.99 0.32 
umd_CPZ       1.61 2.06 0.04 0.20 0.40 0.69 
Cross-sect ional R
2
 0.51   0.50   0.51   0.49   
chi-squared 4.13   14.51   2.69   11.59   
p-value 0.94   0.15   0.98   0.31   
The Table reports the results of Fama-Macbeth regressions, with sh-t and sh-p denoting the t-test and p-values from the Shanken (1992) errors-
in-variables adjusted tests.  The factors are rmrf, the market risk premium, hmls and hmlb, the decompositions of the hml factor as in Zhang 
(2008), MMB_CPZ, the mid-cap minus large cap factor, smb_CPZ, here the mid-cap minus the large-cap return (small firms being excluded 
from this largest firms portfolio), BHML_CPZ and SHML_CPZ the decompositions of the hml_CPZ portfolio, all as described in Cremers et al. 
(2010). 
 
